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 Introduction 
 
Group II introns – ai5γ 
 
In the beginning of the 80s of the last century the finding that an intervening region in 
the 26S ribosomal RNA of Tetrahymena thermophila is able to catalyse its own 
excision from the precursor RNA (Kruger et al., 1982) and that the RNA moiety of 
ribonuclease P is the catalytic subunit of the RNP (Guerrier-Takada et al., 1983) 
triggered a paradigm shift concerning the functions of RNA. RNA was no longer only a 
short-term mobile information carrier but a molecule able to show complex catalytic 
activity. 
The mentioned self-splicing intervening region turned out to be a member of a new 
class of ribozymes, the so-called “group I introns”. Another class of self-splicing introns 
differing in their structure from group I introns have been found in organellar genomes 
of fungi and plants as well as in some bacterial genomes (Michel et al. 1989). Being 
able to carry out phosphotransesterification too, the splicing mechanism differs. 
Interestingly its mechanism resembles nuclear pre-mRNA splicing by the spliceosome, 
in which as in ribosomes (Nissen 2000) the ribonucleic part is carrying out the catalytic 
activity (Valadkhan, 2007). According to the later discovery this group of self-splicing 
introns were called “group II introns”. 
Group II introns are among the largest known catalytic RNA molecules ranging from 
500 to 1000 nucleotides. They are generally poorly conserved in their primary sequence, 
 
 
 
 
 
 
 
Fig1: Conserved secondary 
structure of group II introns. 
Domains are labelled in roman 
numbers I-VI. 
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but the secondary structure shows high conservation (Michel, 1989). The secondary 
structure map of group II introns shows some very interesting characteristics. It consists 
of 6 domains protruding from a central wheel (Fig. 1). 
In contrast to group I introns there are functional structure elements established by base-
pairing or coaxial stacking involving different domains (Qin and Pyle 1998). On the 
other hand a ribozyme derived from the group II intron ai5γ folds into a compact 
structure despite this lack of long-range secondary structure elements indicating that 
long-range tertiary interactions are present (Swisher et al. 2001). Ai5γ is found in the 
Cox1 gene in the mitochondrial genome. Therefore its efficient splicing is crucial for a 
functional respiratory chain in yeast. Most studies on ai5γ were carried out in vitro 
under high salt conditions and elevated temperature. The collapse of this group II intron 
requires high amounts of magnesium (Swisher et al. 2001). 
 
 
Fig.2: Secondary structure of group II intron ai5γ. Domains are indicated in Roman numbers I-VI. 
Tertiary interactions are shown in Greek letters. EBS (exon binding sites) and IBS (intron binding site) 
interact. DII and IV are only shown partially (adapted from .  
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Splicing mechanism 
 
Group II introns most prominent catalytic activity is to excise from precursor mRNA 
forming a lasso like structure, the so-called lariat (Peebles 1986). Remarkably the same 
lariat spliced intron can be found in spliceosomal introns suggesting a common ancestor 
of both pathways (Seetharaman et al. 2006). 
Most of the data available on splicing of group II introns were gained in studies 
(Fedorova and Zingler 2007) carried out under high salt conditions in vitro.  
 
Forward splicing 
 
The splicing activity of group II introns consists of two transesterification steps 
(Fedorova and Zingler 2007), which are carried out sequentially. In the first step the 
2’OH of a highly conserved bulged Adenosine in D6 attacks the phosphate at the 5’ 
splice site releasing the 5’-exon while forming a lariat like structure. The released 5’-
exon remains bound to the intron by base pairing interactions and its free 3’OH is 
positioned correctly to attack the phosphate at the 3’ splice site resulting in an excised 
intron and ligated exons. 
Alternatively a H2O molecule can act as the nucleophile attacking the 5’ splice site 
resulting in a linear spliced intron. In vitro it was shown that under different salt 
conditions either the bracnching or the hydrolytic pathway is predominant (Daniels et 
al. 1996). 
 
Fig. 3: Branching and 
hydrolytic splicing 
pathway. Adapted 
from Fedorova and 
Zingler 2009 
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Reverse splicing 
 
Spliced group II intron have the possibility to do reverse splicing in both the lariat 
(Augustin et al. 1990) and the linear form (Roitzsch and Pyle 2009). In fact both steps 
of forward splicing are reversible although considerably slower. It has also been shown 
that reverse splicing does not only work with RNA but also with DNA targets (Mörl et 
al. 1992). Reverse splicing therefore is the first step to intron mobility. In order to act as 
a mobile genetic element an intron-encoded protein (IEP), the so-called “maturase” is 
required (Matsuura et al. 2001). Maturases are encoded in many group II introns and 
typically consist of a reverse transcrptase, an endonuclease and an RNA binding domain 
(Lambowitz and Zimmerly 2004). Anyhow, ai5γ neither has an IEP nor is able to act as 
a mobile genetic element. Nevertheless the ability for reverse splicing further expands 
the importance of group II introns. 
Recently it was shown, that also linear introns resulting from hydrolytic splicing are 
able to catalyse efficient reverse splicing (Roitzsch and Pyle 2009). 
 
 
Domains 
 
Domain 1: 
 
Domain 1 is the largest of the six domains. Together with the finding that in the folding 
of ai5γ D1 folds first (Su et al. 2005) D1 was proposed to act as a folding scaffold 
allowing subsequent docking of other domains and forming the core structure. This is 
also consistent with folding of D1 being the rate-limiting step. It is inevitable for the 
catalytic activity of the ribozyme together with domain V (Koch et al. 1992). 
Harbouring two 5’-exonic substrate recognition sequences (EBS1 and EBS2) D1 is also 
responsible for binding the complementary regions at the 3’-end of the 5’-exon (Qin and 
Pyle 1998) defining both splice sites. Additionally, EBS1 and EBS2 in D1 are essential 
for targeting RNA or DNA substrates in reverse splicing. Folding of D1 was shown to 
be independent of other domains (Qin and Pyle 1997).  
D1 forms several intra- and interdomain tertiary interactions (Fig. 2). The α−α’ 
interaction are required for splicing in vitro. It plays an important role in folding of ai5γ 
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(Waldsich and Pyle 2007), facilitates binding of the exon splicing site (Qin and Pyle, 
1998) and is helping in campaction of ai5γ (Waldsich and Pyle 2007). β−β’ interaction 
is found in a subset of group II introns (Qin and Pyle 1998) although its function is still 
unclear and it is not necessary for splicing it was found to play a role in compaction 
(Waldsich and Pyle 2007). ε−ε’ plays an important role in forward splicing and may 
help in defining the 5’ exon splicing site (Jacquier and Michel 1990). Three tertiary 
interactions were identified between D1 and D5, the catalytic center of group II introns: 
ζ−ζ’ and κ−κ’ are important for docking of D5 in D1, while λ−λ’ is taking part in 
catalysis and puts D5 close to the 5’ splicing site making it an important factor of the 
formation of the active site together with the ε−ε’ contact as involved residues are 
proximal to the dinucleotide bulge in D5 and J2/3, both key players in active site 
organisation (Fedorova and Pyle 08). θ−θ' is proposed to be responsible for structural 
stabilisation of the native structure (Costa et al. 1997). Additionally, D1 contains an 
asymmetrical internal loop, the “coordination loop”, that is proposed to align all 
components necessary for splicing (DeLancestre et al. 2005) and even more importantly 
acts as the binding site for the bulged A880 that is responsible for the branching 
pathway in forward splicing (Hamill and Pyle 2006). 
 
Domain 2 
 
The function of D2 is still unclear. Its deletion hardly has any effect on cis-splicing 
activity  (Qin and Pyle 1998) although the θ−θ’ interactions where still present. 
However D2 forms long-range tertiary contacts to D1, θ−θ', and D6, η−η' (Costa et al. 
1997). 
 
Domain 3 
 
Although shown to be dispensable for catalysis (Koch 1992) DIII is enhancing the rate 
of catalysis dramatically (Fedorova et al. 2003, Fedorova and Pyle 2005) making it a 
catalytic effector. It was shown that D3 is partly protected against hydroxyl radicals 
with one of the most highly protected regions of the ai5γ derived ribozyme D135 at the 
internal loop of the basal stem indicating contacts with the active site (Swisher et al. 
2001, Fedorova and Pyle 2008). The µ-µ’ tertiary interaction with D5, identified by 
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NAIS analysis (Fedorova and Pyle 2005), is emphasizing the important role of D3 at the 
active site center of group II introns. 
 
Domain 4 
 
D4 contains an open reading frame coding for the maturase protein in several but not all 
group II introns. The maturase is required for mobility (Lambowitz and Zimmerly 
2004). It was shown that D4 of the LI.LtrB group II intron contains a high-affinity 
binding site for the maturase protein LtrA (Watanabe and Lambowitz 2004). Since D4 
is located at the surface of the intron it might actually serve as a general binding 
platform (Fedorova and Zingler 2007). The ai5g group II intron does not encode for a 
maturase. 
 
Domain 5 
 
D5 is strictly required for catalysis. It is the most conserved domain and docks into D1 
via two tetraloop-receptor interactions, ζ−ζ' and κ−κ' (Costa and Michel 1995, 
Boudvillain and Pyle 1998). D5 harbours two catalytically very important substructures: 
the dinucleotide bulge (Schmidt et al. 1996) and the catalytic triad (Boulanger et al. 
1995), the latter also found in the U6 snRNA of the spliceosome (Valadkhan and 
Manley 2001). The backbones of this two substructures are brought closely together 
resulting in the formation of a negatively charged pocket that complexes two Mg2+-ions 
accessible to the 5' and 3' splice sites (Toor et al. 2008). EBS1 as well as the 5' and 3' 
end of the intron are positioned closely to the bulge suggesting a two metal ion 
mechanism in catalysis (Steitz and Steitz 1993). D5 also interacts with the highly 
conserved nucleotides of the linker region between D2 and D3 (J2/3), which seem to 
play a crucial role in catalysis. The most highly conserved nucleotides in D5 are found 
in the catalytic triad AGC, where the G (G817 in ai5γ) is invariant. The functions of this 
invariant G are interesting as its major groove atoms play a crucial role in catalysis, 
while minor groove substituents facilitate ground-state binding of D5 to the ribozyme 
core (Konforti et al. 1998).  
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Domain 6 
 
D6 contains the highly conserved bulged Adenosine, which serves as a branch point in 
the lariat forming splicing pathway (Fedorova and Zingler 2007). 
 
 
Folding of ai5γ 
 
In order to fulfil its catalytic function, an RNA molecule has to adopt its native 
structure. Especially for large RNAs, like ai5γ, folding is a very complex phenomenon. 
Considering the primary sequence, the number of building blocks is very limited 
compared to proteins (Herschlag 1995). Furthermore nucleotides show far less diversity 
in size and physiology than amino acids do. These attributes generally hinder RNA to 
adopt a certain structure. At the level of secondary structure the high thermodynamic 
stability of RNA helices compared to protein a-helices pose a problem in RNA folding 
(Herschlag 1995). Thus kinetic traps are likely to arise. Additionally problematic is the 
establishment of a tertiary fold mediated by 2’- 
hydroxyls, phosphoryl groups, metal ions or by the formation of nonstandard base/base 
interactions, which can further stabilize misfolded species (Herschlag 1995). 
It is impossible to derive an RNA secondary structure from its sequence for large RNAs 
(Schroeder et al. 2004). Considering on one hand the low conservation of primary 
sequence of group II introns that adopt the same secondary structure and on the other 
hand the existence of RNAs like riboswitches that are able to adopt different structures 
according to their environment, this might never be possible. 
The folding of a RNA molecule is hierarchic (Schroeder et al. 2004). First secondary 
structure elements involving proximate regions are built. Afterwards, coaxial stacking 
of helices and long-range tertiary interactions are formed, eventually resulting in the 
final and native structure. The establishment of secondary and tertiary interactions lead 
to a more compact species. This Mg2+-induced compaction happens mostly very fast in 
less than 50ms. But interestingly the compaction of ai5γ needs more than 30s (Pyle et al. 
2007). 
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Global and local folding events in ai5γ 
 
Early studies dealing with the solvent accessibility of group II introns using hydroxyl 
radical footprinting showed that 40% of the ai5γ D135 ribozyme was protected from 
cleavage (Swisher et al. 2001). Phylogenetically conserved and catalytically important 
regions were highly internalized and ai5γ identified as a tightly folded RNA. Hydroxyl 
footprinting revealed that all regions of D135 become protected at the same time and 
Mg2+ concentration (Swisher et al. 2001). Similar results for Mg2+ dependence and the 
timescale were found in global molecular compaction (Su et al. 2003 and 2005). This 
collapse of the unstructured RNA was further differentiated. First there is a partial 
collapse due to secondary structure formation in the presence of K+ called the “unfolded 
state” (Su et al. 2003). In the presence of high levels of Mg2+ the tertiary structure is 
obtained resulting in further compaction. Furthermore, D135 can do rounds of folding 
and unfolding without loosing its activity; the energy for unfolding and folding are the 
same and like folding unfolding is done in a cooperative manner (Su et al. 2003). 
 
Kinetic traps 
 
As mentioned before compaction is relatively slow in D135 compared to folding of 
orther large ribozymes. This could be explained by the arising of kinetic traps that have 
to be resolved in order to allow native structure formation as with the Tetrahymena 
group I intron (Treiber et al. 1998).  
In that case subdenaturing concentrations of urea should reduce folding time (Pyle et al. 
2007). However, neither catalysis nor compaction are accelerated by adding of urea (Su 
et al. 2003, Fedorova et al. 2007). Furthermore, stable misfolded species should appear 
on a native gel since its radius would differ from both the unfolded as well as the native 
structure (Pyle et al. 2007). 
 
Folding control element 
 
Another explanation for the slow collapse of ai5γ is the necessity of forming a small 
nucleation element of folding in an Mg2+ dependent manner. Compaction and formation 
of long-range tertiary interactions would depend on the formation of this substructure. 
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It was shown that D1 folds independently (Qin and Pyle 1997) and that its footprinting 
pattern resembles its counterpart in D135 (Su et al. 2005). Furthermore D1 and D135 
need the same Mg2+ concentration for local folding and molecular compaction. 
Additionally all regions of D1 internalize at the same time (Su et al. 2005). D1 once 
folded can independently bind an exonic substrate and folding of D1, D13, D15 and 
D135 show the same rate constant implying that D1 folding is the rate limiting step in 
the folding pathway of the ai5γ group II intron (Su et al. 2005). Therefore D1 is a 
folding scaffold for the docking of other domains and contains an obligate intermediate 
along the folding pathway of D135 (Su et al. 2005). In D135 D3 and D5 dock 
independently into D1, which is further evidence for the importance of folding of D1 in 
the collapse of D135. 
To narrow down the region being responsible for the slow collapse of D135, Nucleotide 
Analogue Interference Mapping (NAIM) was carried out (Waldsich and Pyle 2008). In 
this approach nucleotide analogues carrying single-atom modifications are incorporated 
randomly in the RNA. By adding 100mM Mg2+ tertiary folding is triggered. After ~t1/2 
for compaction the RNA is loaded on a native gel to separate folded from unfolded 
D135. Iodine sequencing then reveals important sites for D135 collapse. All NAIM 
signals were located in D1 underlining its crucial role in folding. The strongest NAIM 
effects were found within the D1 central stem around the so-called κ−ζ element. It was 
revealed that the formation of the κ−ζ element is Mg2+ dependent. Since the amplitude 
for compaction but not the rate constant is dependent on the Mg2+ concentration a 
conformational capture mechanism was proposed (Waldsich and Pyle 2008) meaning 
that the proper conformation of the κ−ζ element is captured by Mg2+ inducing the 
collapse of D1. Additionally it was shown, that the formation of certain helical elements 
in the central stem of D1 is dependent on Mg2+ indicating that not only tertiary contacts 
but also secondary structure formation plays an important role on the collapse of ai5γ 
(Waldsich and Pyle 2008). Tertiary contacts then stabilize the collapsed structure and 
subsequent docking of D3 and D5 results in the native structure of the ribozyme. With 
these findings it was possible to describe a folding pathway for ai5γ in vitro (Figure 4). 
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Figure 4: The proposed folding pathway of ai5γ in vitro. Here the electrostatically relaxed intron collapses 
slowly to a compact intermediate controlled by the formation of the k-z element. Subsequent docking and 
native structure formation then happens fast. Adapted from Su et al. 2005. 
 
 
Folding in vivo 
 
In the cellular context neither mono- nor divalent ions are present at a concentration 
required for folding of RNA in vitro (Schroeder et al. 2002). Folding and in turn 
splicing of ai5γ depends on the activity of the DEAD-box protein Mss116p (Seraphin et 
al. 1987). 
Generally little is known about folding of RNA in vivo. Despite the difference in ion 
concentration, the flanking sequence context of RNA in vivo is not available in vitro and 
has significant influence in RNA folding rates (Cao and Woodson 2000). Additionally, 
observed misfolding of the Tetrahymena group I intron in vitro can be significantly 
reduced if the flanking sequence context is present in vivo (Nikolcheva and Woodson 
1999). Furthermore folding of RNA in vivo happens co-transcriptionally, which impacts 
folding due to its directionality and velocity as well as pausing of the RNA Polymerase 
(Schroeder et al. 2002). 
compact 
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Maybe the biggest difference of RNA folding in vitro and in vivo results from the 
presence of proteins, which can assist in folding in vivo. 
One class is formed by the so-called RNA chaperones (Herschlag 1995, Rajkowitsch et 
al. 2007). These proteins are found to act on RNA non-specifically by resolving 
misfolded intermediates or by impeding kinetic traps. They are ATP independent and 
bind RNA non-specifically. StpA, a RNA chaperone found in E.coli, for example shows 
enhanced chaperone activity if its RNA binding is weakened by a mutation (Mayer et al. 
2007). Consistent with this weak binding RNA chaperones are also not needed to 
maintain the native structure of a RNA (Rajkowitsch et al. 2007). Nevertheless little is 
known about the mechanisms and relevance of RNA chaperones in vivo. 
Another type of proteins assisting in RNA folding are specific binding cofactors that are 
stabilizing an on pathway intermediate or the native state itself. An example for this can 
be found in CPB2 that captures its target RNA the bI5 group I intron from the collapsed 
to the native state by binding (Webb and Weeks 2001). Cyt18, a group I intron splicing 
factor, binds to a defined structural element and thereby induces compaction of the 
intron and stabilizes its tertiary structure (Mohr et al. 1992). The action of these proteins 
is required to maintain the native structure (Rajkowitsch et al. 2007). Another point of 
action for proteins in RNA folding is ion homeostasis since especially Mg2+ plays a 
crucial role in folding of most large RNAs as shown for group II introns and the 
magnesium transporter Mrs2p (Gregan et al. 2001). 
A class that assists in RNA folding and has recently drawn a lot of attention to it is the 
so-called DEAD-box helicase family (Cordin et al. 2006). Helicases are ATP dependent 
proteins that are able to unwind both RNA and DNA strands (Pyle 2008). Mss116p was 
proposed to act as a chaperone (Delcampo et al. 2007) using its unwinding activity to 
resolve kinetic traps and thereby allow native structure conformation. In contrary the 
same protein was found to be able to assist in folding of the group II intron ai5γ without 
unwinding but by stabilization (Solem et al. 2006).  
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DEAD–box proteins 
 
The family of DEAD-box proteins is widely spread in all eukaryotes and most 
prokaryotes (Cordin et al. 2006). They are part of the helicase superfamily SF2 and 
share 9 conserved motifs (Figure 5) including the Walker B motif which is responsible 
for its name due to its amino acid sequence D-E-A-D (Pyle 2008). DEAD-box proteins 
are organized in Domain 1 and 2 which harbor the conserved motifs. These domains are 
structurally conserved and superimposable with a RecA fold (Pyle 2008). Some DEAD-
box proteins have an additional alpha helical domain Dα linking the two RecA folds to 
a C-terminal domain, which is arginine rich and proposed to interact with the negatively 
charged RNA backbone (Solem et al. 2006).  
A vast majority of processes involving RNA are on one or another hand dependent on 
the activity of DEAD-box proteins. These processes involve cellular functions as 
different as ribosomal biogenesis and RNA decay, where DEAD-box proteins are 
required for structural reorganisation (De la Cruz et al. 1999). 
 
 
Motifs 
 
The Q motif, which is found at the N-ternegative, is necessary for efficient binding of 
single stranded RNA and for conformational changes resulting from nucleotide binding 
and ATP hydrolysis. It might therefore play an important role in acting as a sensor for 
bound substrates triggering hydrolysis of ATP (Cordin et al. 2004). 
Motif I, also called Walker A motif, is found in all helicases. It is inevitable for ATPase 
as well as unwinding activites. It is conserved in structure and sequence. The 
 
Figure 5: Conserved motifs with consensus sequence for DEAD box proteins. Showing >60 % homology. 
Adapted from Cordin et al. 2006 
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importance of motif I is highlighted through the interactions with the Q motif, motif II 
and III as well as the phosphates of ATP (Figure 6, Cordin et al. 2006). 
Motifs Ia and Ib are only poorly understood but crystal structures showed that they are 
involved in RNA binding together with motif IV and V (Cordin et al. 2006). 
Motif II is also known as Walker B motif and necessary for the ATPase activity. It 
interacts with motif I, III and IV and in that possibly forms the ATP binding pocket 
(Cordin et al. 2006). 
Motif III, called the SAT motif due to its sequence, is coupling ATPase and unwinding 
activities. While mutations lead to an abolishment of unwinding activity, ATP binding, 
hydrolysis and RNA binding are still present (Pause and Sonenberg 1992). 
Motif IV is still very poorly understood and its functions are unknown. 
Motif V was suggested to bind RNA together with motifs Ia, Ib and IV. It might also be 
involved in signalling RNA binding to the ATPase domain and thereby regulating ATP 
hydrolysis (Schneider et al. 2004). 
Motif VI is located between domain 1 and 2 (Figure 6). It is important both for ATPase 
activity and RNA binding. Motif II and VI have different consensus sequences in 
DEAD and DExH-box proteins suggesting a covariation and potential communication 
between those two motifs (Cordin et al. 2006). 
 
 
 
 
 
Figure 6: Crystal structure of 
full length DEAD box protein 
eIF4A. Showing positions of 
the conserved motifs. 
Adapted from Cordin et al. 
2006. 
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Unwinding activity 
 
Although SF2 including DEAD-box proteins has originally been defined as helicases 
they display a diversity of functions (Pyle 2008). Namely the DEAD-box proteins 
behave differently compared to other SF2 helicases. They have a different structure and 
are nonprocessive, meaning they are not translocating continuously and directionally on 
a filament like a RNA strand while for example seperating it (Pyle 2008). Furthermore, 
they have another strategy for binding and coupling their substrate and ATP hydrolysis. 
ATP binding and hydrolysis happens between the two RecA folds domain 1 and 2. 
Compared to processive SF2 proteins the connection between the two RecA domains is 
more flexible and only rigidification by binding of its substrate RNA or other proteins 
allows ATP binding (Jankowsky and Fairman 2007). By binding RNA and ATP domain 
1 and 2 function as a clamp changing their orientation (Figure 7). Another important 
difference between DEAD-box proteins and the rest of the SF2 proteins can be found in 
the structure of bound RNA. While RNA bound by processive SF2 proteins show an 
extended shape its backbone is severely bent when associated to DEAD-box protein, 
which was revealed by cocrystallisation of SF2 helicases and a RNA substrate 
(Jankowsky and Fairman 2007). Interestingly DEAD-box proteins bind the phosphate 
backbone exclusively without the involvement of the bases. 
 
 
 
 
Figure 7: Conformational 
changes of the DEAD box 
protein Vasa upon RNA and 
ATP binding. Adapted from 
Pyle 2008. 
 
The nonprocessive character of DEAD-box proteins does not allow extensive strand 
separation.  In contrast to for example viral DexH proteins the length of unwinding is 
limited by 2 helical turns and is often even less. 
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The actual mode of unwinding by DEAD-box helicases is still unknown. As in all 
helicases ATP binding and hydrolysis is needed for its helicase activity. It is also known 
that substrate binding is greatly enhanced in the presence of ATP and reduced in its 
absence or the presence of ADP differing from processive helicases (Yang and 
Jankowsky 2005). For the DEAD-box protein Ded1 it was proposed, that during 
binding and hydrolysis of ATP a transient conformational state is destabilizing duplex 
and stabilizing single stranded RNA (Jankowsky and Fairman 2007). In contrast it was 
suggested for Vasa, that the unwinding might be a more active process (Sengoku et al. 
2006). In this model the protein exerts force on the duplex RNA to actively wrench it 
apart as it kinks bound single stranded RNA in a way that does not allow duplex 
formation. Nevertheless this could also imply that Vasa acts by stabilising transient 
single strand RNA and thereby driving the reaction toward the unwound state (Pyle 
2008). 
 
 
Other functions 
 
Although DEAD-box proteins are mostly referred to as helicases many of them do not 
unwind RNA (Cordin et al. 2006). Strikingly until now many other functions of DEAD-
box proteins have been revealed as for example RNA stabilisation, protein displacement 
or transcriptional regulation (Pyle 2008). 
A very interesting additional function revealed especially in DEAD-box proteins with a 
basic C-terminal protein as Ded1 or Mss116p is strand annealing activity (Yang and 
Jankowsky 2005). Ded1 stabilizes duplexes in the absence of ATP while establishing 
equilibrium between unwinding and annealing in its presence. This might be a key 
function in the assembly and disassembly of RNA structures. 
Many different DEAD-box proteins are required for structural organisation or folding of 
RNA as with self-splicing group II introns. But although a lot of those do so by 
unwinding kinetically trapped substructures, other modes of actions have to be present. 
In the case of Mss116p it was proposed that not unwinding of a misfolded structure but 
stabilizing leads to the establishment of the native structure of the ribozyme (Solem et 
al. 2006). 
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Mss116p 
 
Mss116p was identified in Saccharomyces cerevisiae in a screen for nuclear mutants 
that are unable to grow by respiration on nonfermentable carbon sources when their 
mitochondrial DNA contain introns, but not when their mtDNAs lack them (Seraphin et 
al. 1987). In S. cerevisiae splicing of all mitochondrial introns is facilitated by Mss116p 
in vivo (Huang et al. 2005). In the case of group II introns this effect was very severe 
with a reduction in splicing of 88-97%. It was shown in the same study that another 
DexH/D-box protein Cyt19 could partially rescue the phenotype of a mss116 knock out 
strain. Mss116p also plays a role in mitochondrial translation (Huang et al. 2005) and its 
overexpression can partly rescue defects of ∆suv3 strains, a helicase of the degradosom 
(Minczuk 2002). Therefore Mss116p seems to be a multifunctional enzyme involved in 
different RNA dependent processes. 
Mss116p also stimulates splicing of the group II intron ai5γ under near-physiological 
conditions in vitro lowering the needed [Mg2+] significantly (Solem et al. 2006, Halls et 
al. 2006). Mss116p hydrolyzes ATP after RNA binding and unwinds short dsRNA with 
a 3' or 5' single stranded overhang as well as with a blunt end (Halls et al. 2006). This 
previously led to the assumption that resolving of kinetic traps is the mode of action in 
DEAD-box proteins and that Mss116 acts as an ATP-dependent RNA chaperone 
(Huang et al. 2005). 
 
 
 
 
 
 
 
Figure 8: A schematic of the 
architecture of Mss116. 
Below the 9 conserved 
motifs are shown and their 
location. 
 
Q I Ia Ib II III V VI IV 
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To shed more light on the mechanism of Mss116p Solem et al. (2006) applied Mss116p 
with different mutations to their in vitro splicing and unwinding assays. Of special 
interest were the mutation of motif III (SAT → AAA) that couples ATPase and 
unwinding activity and the mutation of motif I (K158R) which is necessary for ATP 
binding and hydrolysis. The SAT → AAA mutation did not influence RNA and ATP 
binding but reduced RNA stimulated ATPase activity by 80%. More importantly 
unwinding activity was eliminated with the substrate used (Solem et al. 2006) although 
with shorter substrate residual unwinding activity still could be observed (DelCampo et 
al. 2007). Nevertheless although splicing was reduced in a minor manner, which might 
result from reduced ATPase activity, it still resulted in about half the amount of mRNA 
compared to wild type Mss116. In contrast the K158R mutation, which abolishes ATP 
binding as well as ATPase and unwinding activities while maintaining RNA binding, 
shows no spliced product (Solem et al. 2006). These results show that ATP binding and 
hydrolysis is necessary for splicing of ai5γ whereas unwinding activity is not. This is 
further indicated by the elevated ratio between Mg2+ and ATP needed for efficient 
Mss116p-stimulated splicing of the group II intron ai5γ (1mM ATP versus 8mM Mg2+), 
which was proposed to be optimal in nearly equimolar concentrations for unwinding 
activity (Iost et al. 1999). This large excess of Mg2+ additionally inhibits the helicase 
activity of Mss116p (Solem et al. 2006). 
Consistent with the unimportance of unwinding activity for splicing of the ai5γ gintron 
is the fact that ai5γ folds properly in vitro without misfolding (Su et al. 2003 and 2005). 
A proposed mechanism of Mss116p is stabilising an on pathway intermediate instead of 
unwinding RNA. This would correlate with the finding of the folding control element 
κ−ζ which has to be formed in order to trigger the collapse of ai5γ (Waldsich and Pyle 
2008). ATPase activity might be needed for conformational changes required for 
substrate release. 
To understand the interchangeability of Mss116p and Cyt19, Solem et al. (2006) 
applied a variety of different DEAD-box proteins to their in vitro splicing assay and 
found out that additionally to Mss116p and Cyt19 also Ded1 could promote splicing, 
while NS3, Dbp8 and Dp8/Esf2 couldn't. All 6 contain the helicase core but only 
Mss116, Cyt19 and Ded1 have a distinct C-terminal domain harboring several arginine 
side chains. It was shown that truncation of this CTD abolished RNA annealing activity 
in Ded1 (Yang and jankowsky 2005) and promotes splicing in Mss116p (Huang 2004). 
 22 
Besides adding of Mss116p lowers the amount of Mg2+ ai5γ needs for establishing its 
native structure significantly (Solem et al. 2006). 
These findings indicate that there is a distinct subgroup of DEAD-box proteins that 
assist in folding of large RNAs by stabilizing on pathway intermediates. Alternatively 
Lambowitz and coworkers proposed Mss116p and related proteins to act as RNA 
chaperones by unwinding misfolded structures allowing native structure conformation 
(Halls et al. 2006, DelCampo et al. 2007). 
 
 
Aims 
 
Up to now a lot of progress has been made in elucidating RNA structure and their 
folding pathways in vitro (Woodson 2005, Williamson 2000, Pyle et al. 2007). It has 
been shown that folding of RNA molecules is diverse in its pathways and dependencies 
of extrinsic factors. While e.g. some group I introns where shown to need RNA 
chaperones to dissolve kinetic traps (Rajkowitch et al. 2007) other RNA molecules do 
not have a rugged free-energy landscape but fold directly into their native structure 
(Pyle et al. 2007). Although the effort in understanding the folding of large RNAs in 
vitro has been enourmous, in vivo only a few studies are available on that topic (Zhang 
et al. 1995, Waldsich et al. 2002, Semrad and Schroeder 1998). 
An interesting extrinsic factor many large RNA molecules need to fold properly in vitro 
is an unusual concentration of Mg2+. This non-physiological amount of divalent ions is 
not present in the actual cellular environment, which raises two questions: how does 
magnesium assist in folding and what cellular factor copes for that? 
Magnesium has two possibilities to influence tertiary folding of RNA. First it can 
interact electrostatically with the phosphate backbone of the RNA molecule in its 
“diffused” form and second it can directly be bound by the RNA backbone in its 
“chelated” (Draper 2005). Since the crystal structure of the O. iheyensis group II intron 
(Toor et al. 2008) revealed several Mg binding pockets both attributes of magnesium 
might contribute to folding of group II introns. Since Mss116p lowers the required 
magnesium level to a near-physiological one (Solem et al. 2006) a linkage between the 
function of this DEAD box protein and Mg2+ is possible. 
 23 
In our work we first wanted to get more insight into the intracellular structure of ai5γ 
comparing it with structural data obtained in vitro at high salt and elevated temperature 
conditions. To do that we used an in vivo DMS chemical probing assay. DMS 
penetrates the yeast cell and all its compartments quickly methylating the N1 of 
adenosines and the N3 of cytosines if they are solvent accessible meaning neither 
involved in hydrogen bonding nor protected by binding of a protein or other ligands. 
With this method it is possible to obtain structural information on both the secondary 
structure and the tertiary structure. Additionally footprints of proteins bound to the RNA 
can be found and therefore binding sites identified. After having information on the 
structure of ai5γ in vivo we wanted to determine the influence of Mss116p or, more 
accurate, of the lack of Mss116p on the structure of ai5γ. To do that we applied the 
same technique on a ∆mss116 strain and compared the DMS pattern to the wild type 
strain RNA to reveal nucleotides with enhanced or protected N1 and N3.  
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Methods 
 
Cell growth and DMS modification 
 
Strains 
 
During my work I used two Saccharomyces cerevisiae strains kindly provided by Philip 
Pearlman (Huang et al 2005). The first one was a wild type strain (MATa ade1 lys1 
ura3-52) that has been used previously to create the second one, a mss116-knock out 
strain (MATa ade1 lys1 ura3-52 mss116∆::kanr). 
 
Cell culture 
 
Yeast strains were grown on YPD plates (1% yeast extract, 2% peptone, 2% glucose, 
2% agar). Single colonies were picked, inoculated in 5 ml liquid YPD and grown 
shaking over night at 30°C. This preculture was transferred to 100 ml YPR with 2% 
raffinose instead of glucose and grown shaking at 30°C until an OD600 of about 1. 
 
DMS modification 
 
The protocol was adapted from Wells et al. (2000). Two times 30 ml of each cell 
suspension were centrifuged at 6000 rpm and 20°C. The cell pellets were resupended in 
prewarmed (30°C) YPD to a volume of 1 ml. One of the sample was treated with 50 
mM end concentration of DMS (10.7 M) and vortexed briefly. Immediately after DMS 
treatment all samples were put on 30°C shaking at 300 rpm for 2 min. After this they 
were put on ice and DMS modification stopped with 0.7 M end concentration of β-
mercaptoethanol (14.3 M) and 50 µl isoamylalcohol (98%) and the samples vortexed 
intensely. The cells were then pelleted at 6000 rpm at 4°C and the cell pellet was 
resuspended in 1 ml TM-buffer. Again β-mercaptoethanol was added as before to the 
DMS treated cells and all samples were pelleted again under same conditions. After 
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removing the supernatant cell pellets were frozen at –80°C for at least 30 min to 
maximum over night. 
 
 
RNA preparation 
 
RNA preparation with hot acid phenol extraction 
 
Frozen cells were first resuspended in 600 µl AE buffer and 100 µl 10 % SDS. Then the 
resulting cell suspension is divided into two 1.5 ml tubes that contain each 700 µl 
preheated (65°C) phenol pH 4.5. 
After vortexing briefly the tubes were put into liquid nitrogen until completely frozen. 
Then the samples are thawed at 65°C, vortexed for 30 seconds and shaken at 65°C for 4 
min. This freezing-thawing step was done 3 times. 
Then the samples were centrifuged 5 min at 13200 rpm and room temperature. The 
aqueous phase was transferred to tubes containing 700µl PCI. After strong vortexing for 
30 seconds the samples were centrifuged as before and the aqueous phase transferred to 
700 µl CI. The same procedure as with PCI extraction resulted in an aqueous phase 
containing RNA that was precipitated with 2.5x Volume ethanol / 0.3 M NaOAc for at 
least 1 hour at –20 °C. After discarding the supernatant and drying the pellet, the latter 
was resuspended in 100 µl ddH2O. To get rid of residual DNA 3 µl DNAse I [2 U/µl], 
0.4 µl RNAse Inhibitor [40 U/µl] and 12 µl 10 x DNAse I buffer was added and the 
reaction incubated on ice for 1 hour. After this PCI and CI extraction was carried out as 
before and the RNA precipitated with 2.5x Volume ethanol / 0.3 M NaOAc and 2 µl 
0.5M EDTA pH 8.0 for at least 1 hour at –20 °C finally resuspending the RNA pellet in 
10 µl ddH2O. 
Additionally this procedure was modified by a douncing step introduced after 
resuspending the frozen cells. In this douncing step the cell wall was to be actively 
disrupted by shear forces. 
 
 26 
RNA preparation with glass beads  
 
First 2 g of acid treated glass beads (0.2 mm) were put into a 15 ml Falcon tube. 1 ml of 
LETS buffer equilibrated phenol pH 4.5 was added. The frozen cell pellet was 
resuspended in 800 µl ice-cold LETS buffer and added to the glass beads/phenol mix. 
The solution was then vortexed strongly at 4°C for 3 minutes. After adding another 1.5 
ml ice-cold LETS buffer and short vortexing the sample was centrifuged 5 min at 5000 
rpm. The aqueous phase was extracted first twice with 1.5 ml PCI by vortexing and 
centrifuging as above and then once with 1.5 ml CI. After this the aqueous phase was 
precipitated with 2.5x Volume ethanol / 0.3 M NaOAc for 3 hours at –20°C, centrifuged 
as before and resuspended in 100 µl ddH2O. DNA digestion and subsequent PCI and CI 
extraction were done as before and the pellet resuspended in 10 µl ddH2O. 
Additionally this procedure was modified by first treating the cells as in “RNA 
preparation with hot acid phenol extraction” until the freezing-thawing step was applied 
and after this switching to glass beads as described. 
 
RNA preparation with NucleoSpinTM RNA L Kit 
 
RNA was prepared according to the provided protocol. After elution the RNA was 
precipitated with 2µl 0.5 M EDTA pH 8.0 and 2.5x Volume ethanol / 0.3 M NaOAc 
over night and centrifuged at 4°C and 16000 x g for 1 hour. After discarding the 
supernatant and drying the pellet was resuspended in 10 µl ddH2O. 
 
RNA preparation with RibopureTM-Yeast Kit 
 
RNA was finally prepared using RibopureTM-Yeast Kit by Ambion according to the 
protocol. The main steps are cell breakage with Zirconia beads, phenol extraction of the 
lysate and glass-fiber filter purification. The vortexing (cell breakage) step was done at 
4°C for 15 min and the elution volume was 100µl of elution solution. After DNA 
digestion the RNA was again precipitated with 2µl 0.5 M EDTA pH 8.0 to remove 
nucleotides and 2.5x Volume ethanol / 0.3 M NaOAc over night and centrifuged at 4°C 
and 16000 x g for 1 hour. After discarding the supernatant and drying the pellet was 
resuspended in 10 µl ddH2O. 
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Determination of RNA concentration 
 
0.5 µl of the prepared RNA were diluted in 500 µl dH2O and A260, A280 as well as A320 
were measured. After checking the ratio of A260:A280 to ensure proper removal of 
ethanol, phenol or proteins, the concentration of RNA was determined with 
 [RNA] µg/µl = (A260 - A320) ∙ 40. 
 
 
RNA quality controls 
 
Quality control for RNA on agarose gel 
 
To get a first glance at RNA quality 1 µg RNA was loaded on a native 1% agarose gel 
(in 1x TBE). The gel ran at 100 mA as limiting parameter. 
 
RT-PCR for analysis of mitochondrial DNA contamination 
 
To check for contamination of mitochondrial DNA in the RNA solution reverse 
transcription with subsequent PCR was applied. 
For reverse transcription 4 µl of a 0.5 µg/µl RNA solution where mixed with 10 µl 
ddH2O and 1µl RP_ai5g_R primer.  The reaction was then incubated for 5 minutes at 70 
°C and subsequently put on ice for 5 minutes. Then 1 µl MMLV reverse transcriptase 
(200 U/µl), 5 µl 10x MMLV-RT buffer, 1.3 µl 10 mM dNTPs, 1µl RNAse Inhibitor (40 
U/µl) and 2.7 µl ddH2O were added. The reaction was put on 42°C for 1 hour for primer 
extension and then 15 minutes on 70 °C for enzyme deactivation. After this 1 µl RNAse 
H (5 U/µl) was added and the RNA digested for 20 minutes at 37°C. Finally the RNAse 
H was inactivated by putting the sample on 65°C for 20 minutes. 
Thereafter the PCR reaction was set up by mixing 10 µl 5x GoTaqTM Green buffer, 1 µl 
10 mM dNTPs, 0.5 µl of each 100µM primer RP_ai5g_R, RP_ai5g_M, RP_ai5g_F, 
0.25 µl GoTaq DNA Polymerase (5 U/µl) and 32.25 µl ddH2O. To check if the desired 
RNA is present 5 µl of the cDNA sample from the previous RT reaction was added. For 
negative control 5 µl ddH2O was added instead. For mitochondrial DNA check 2µg 
RNA was applied in a volume of 5 µl. The PCR was run with following parameters: 
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First the sample was denatured 5 minutes at 95°C. Then a denaturing step of 95°C for 
45 seconds, an annealing step of 58°C for 45 seconds and an elongation step of 72°C for 
2 minutes were applied for 30 cycles. The final extension was carried out at 72°C for 10 
minutes and the reaction was kept on 4°C until loaded on a 1% agarose gel for analysis. 
 
PCR for analysis of nuclear DNA contamination 
 
To check for nuclear DNA contamination PCR using primers for nuclear encoded 
Mss116p was applied. 2 µg RNA in a volume of 5 µl were mixed with 10 µl 5x 
GoTaqTM Green buffer, 1 µl 10 mM dNTPs, 0.5 µl of each 100µM primer CW01F, 
CW01R, 0.25 µl GoTaq DNA Polymerase (5 U/µl) and 33.25 µl ddH2O. For positive 
control the plasmid CW01 carrying the Mss116 gene was used instead of RNA. For 
negative control 5 µl ddH2O was added instead. The PCR was run with the same 
parameters as before. 
 
 
Primer purification and kinasing 
 
Gel purifying of oligonucleotides 
 
Incoming oligonucleotides for reverse transcription were mixed 1:1 with 1x Loading 
Buffer and loaded on a 20% denaturing acrylamide gel. The gel was run with 20 W until 
the Xylene Cyanol marker which runs at 25 nucleotides length reached the second half 
of the gel. Oligonucleotide bands were then identified by UV shadowing. The gel pieces 
were transferred to perforated 0.5 ml PCR tubes, inserted in 1.5 ml Eppendorf tubes and 
centrifuged at top speed for 10 minutes for crushing. 1 ml Elution buffer was added and 
the tubes were shaking overnight at room temperature before 2.5 times the volume was 
added in ethanol (p. a.). The oligonucleotides were precipitated over night at –20 °C, 
centrifuged at top speed and 4°C and resuspended in dH2O. The concentration was 
determined by using following Extinction coefficients:  
εadenine = 15346.6 
εguanine = 11751.8 
εthymine = 9929.7 
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εcytosine = 7623.2 
To account for neighbouring effects a factor of 0.9 was included in calculation. The 
final Extinction coefficient then was determined by 
 εtotal = 0.9 . (εadenine. nadenine + εguanine . nguanine + εthymine . nthymine + εcytosine . ncytosine) 
The concentration of the related oligonucleotide was determined by measuring A260 and 
using the formula 
 concentration (mol/L) = A260/(εtotal . pathlength (cm)) . dilution 
were the pathlength of the cuvette was 1 cm. 
 
Primer Kinase Reaction 
 
Oligonucleotides for reverse transcription were diluted to a concentration of 10 µM. 1 
µl of that dilution (10 pmol DNA) was mixed with 2 µl of 10x T4 polynucleotide kinase 
reaction buffer (NEB), 10µl dH2O, 1 µl T4 Polynucleotide Kinase (NEB, 10 U/µl) and 6 
µl of γ-P32-ATP (6000 Ci/mmol). This solution was incubated for 30-45 minutes at 37 
°C. The reaction was stopped by adding 1µl 0.5 M EDTA pH 8.0 (to remove excess 
ATP) and incubating at 95 °C for 1 min. After cooling down on ice for 2 minutes, 1 µl 
glycogen was added and the labelled oligonucleotide was precipitated with 2.5x 
Volume ethanol / 0.3 M NaOAc for 1h to overnight. After spinning for 1 hour on 4°C 
and top speed and air drying the pellet was resuspended in 30 µl dH2O. 
 
 
Reverse transcription and subsequent gel run 
 
Reverse Transcription using AMV Reverse Transcriptase 
 
For hybridisation 1 µl of 4.5x Hybridisation buffer was mixed with 2.5 µl RNA (40 µg) 
and 1 µl of 5’end P32-labeled primer. This mixture was then incubated at 95°C for 1 
minute and then slowly cooled down to 42°C. For extension a master mix was prepared 
using 0.6 µl Extension buffer, 0.3µl 2.5 mM dNTP mix, 1.0 µl ddH2O and 0.3 µl AMV 
Reverse Transcriptase [10 U/µl]. 2.2 µl of this master mix were added to the annealing 
reaction that was previously cooled down. To obtain sequencing lanes for adenine and 
cytosine 0.75 µl of 1 mM ddTTP (for adenine) or 1 mM ddGTP (for cytosine) was 
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added the respective reactions. The extension reaction was then incubated for 1 hour at 
42°C. To degrade the RNA 1.5 µl 1 M NaOH was added to each reaction, which was 
then again incubated at 42°C for 1 hour. The pH was neutrilized by 1.5 µl 1 M HCl and 
the cDNA precipitated with 1µl 0.5 M EDTA pH 8.0 and 30 µl Ethanol / 0.3 M NaOAc 
pH 5.0 at –20°C for 1 hour to overnight. After this the samples were centrifuged for 1 
hour at 13200 rpm. After discarding the supernatant the pellet was air dried for about 10 
min and resuspended in 8 µl Loading buffer. 
 
Reverse Transcription using ThermoScriptTM 
 
Some regions were GC-rich and had to be mapped at a higher temperature with another 
enzyme in order to get a quantifiable signal. For this ThermoScriptTM was used. For 
hybridisation 2 µl of 4.5x Hybridisation buffer was mixed with 2.5 µl RNA (40 µg), 2.5 
µl ddH2O and 2 µl of 5’end P32-labeled primer. This mixture was then incubated at 
95°C for 1 minute and then slowly cooled down to 55°C. For the extension 0.5 µl 
ThermoScriptTM [15 U/µl], 2 µl 10 mM dNTPs, 1µl 0.1 M DTT, 4 µl 5x cDNA 
Synthesis buffer and 3.5 µl ddH2O were added. To obtain sequencing lanes for adenine 
and cytosine 1.5 µl of 5 mM ddTTP (for adenine) or 5 mM ddGTP (for cytosine) was 
added the related reactions. The resulting reaction was incubated at 55°C for 45 
minutes. Then the sample was put on 85°C for 5 minutes. After adding 4.5 µl 1 M 
NaOH the RNA was digested for 30 minutes. The pH was then neutralized with 4.5 µl 1 
M HCl and the cDNA precipitated as before but with 2µl 0.5 M EDTA pH 8.0 and 60 µl 
Ethanol / 0.3 M NaOAc pH 5.0. 
 
Poisoned Primer Assay 
 
All steps are carried out as described in “Reverse Transcription using AMV Reverse 
Transcriptase”. The only difference is that in the extension mix instead of dNTPs the 
poisoned mix containing ddCTP instead of dCTP is used. 
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Resolving the cDNA pool on a denaturing gel 
 
For resolving the cDNA pool resulting from reverse transcription an 8 % denaturing 
polyacrylamid gel was prepared. This gel was set up with 1x TBE as running buffer. 
The pockets were rinsed with 1x TBE and the gel prerun 1 hour with 40 W. After the 
prerun half of the sample was loaded on the gel and under identical conditions run until 
the Bromphenol Blue dye reached the bottom. The gel was then dried for a minimum 
time of 1 hour and exposed in phosphoimager cassettes from overnight to 3 days, which 
were than scanned on a phosphoimager (GE Healthcare). 
 
 
Analysis 
 
For quantitative analysis of the phosphoimager scans ImageQuantTM (Molecular 
Dynamics, GE Healthcare) was used. 
 
Analysis of wild type strain DMS modification 
 
Line objects of same length were applied to the RT stop control lane and the DMS 
modification lane. The resulting graph was further analyzed with Excel. Sequencing 
lanes were used to assign nucleotides adenosine and cytosine to referring peaks. The RT 
stop control that was not treated with DMS revealed bands that correspond to natural 
stops of reverse transcription. Peaks related to this bands where treated as breaks instead 
of DMS modification. DMS modification intensity was characterized by building the 
sum of all peak heights and calculating the percentage of the individual peak intensities.  
 
Analysis of knock out strain DMS modification 
 
Line objects of same length were applied to the RT stop control lane and the DMS 
modification lane of both the wild type strain and the knock out strain.  DMS 
modification intensities were defined as before. To reveal nucleotides that were 
enhanced in or protected from DMS modification in the knock out strain the ratio 
between DMS intensities of nucleotides carrying DMS modifications were determined 
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(∆mss116 : wild type). Ratios over 1.5 were assigned as medium, over 2.0 as strong 
enhancements. Ratios under 2/3 were assigned as medium, under 0.5 as strong 
protections. 
 
Analysis of the poisoned primer assay 
 
Rectangular objects of the same size were applied to the bands related to pre-RNA and 
mRNA. For background subtraction the same element was also applied to a band 
unrelated to both species. The volume of the objects were defined with ImageQuantTM 
and analyzed with Excel. There the background intensity was subtracted from both 
volumes related to one species. Then the percentage of each species was determined for 
the wild type and knock strain. 
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Materials 
 
Primers 
 
All sequences are written from 5’ to 3’. 
 
Oligonucleotides for mapping ai5γ 
 
Sc82:  GTTACCATTTTAATACACTTG 
Sc160: GTTCCTTCATCTTTTTTTTATAA 
Sc234: GTTTTCAATTAGTGGTGTAAG 
Sc312: TTTCCAATACATAACATCAACC 
Sc375: GTAAATATCTAACTTAGCTCTC 
Sc440:  TTGGTATTATTATTATTTTTTATTATTA 
Sc520: TATTTCTTAATCCAATAATTATTTATA 
Sc588. GCTTTTTATAC 
Sc656: CACCTATAGTATAAGTTAGCAG 
Sc682:  ATAATAATAATATATATATAAATAAAGATAGGC 
Sc745:  ATTTATCAGTTATATATAAACCTCC 
Sc805:  CGGCTCACGCAATATC 
Sc866:  CCCGATAGGTAGACCTTTAC 
Sc-6: GAAAATAGCACCCATTGATAATAC 
 
Primers for analysis of mitochondrial DNA contamination 
 
RP_ai5g_1F: CTTACTACGTGGGACATTTTC 
RP_ai5g_1M: GGTTTATTCTGTTTTATCATAAATACG 
RP_ai5g_1R:  CATATAAAATATAGATAAATAAGAATAATG 
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Primers for analysis of nuclear DNA contamination 
 
CW01F: ACGCGTCGACATGTTGACCTCTATATTGATAAAAG 
CW01R: CGGAATTCCTAATATATGTTGCTGTTTCTACTG 
 
 
Enzymes and Kits 
 
Enzymes 
 
Enzyme 
concentration 
(U/µl) 
Buffer (if used) Company 
AMV Reverse 
Transcriptase 
10  Promega 
MMLV Reverse 
Transcriptase 
200 
10x MMLV RT 
Buffer 
Promega 
GoTaqTM DNA 
Polymerase 
5 
5x Green GoTaqTM 
Buffer 
Promega 
ThermoScript Reverse 
Transcriptase 
15 
5x cDNA synthesis 
Buffer 
Invitrogen 
DNAseI 2 10x DNAse I Buffer NEB 
RNAse Inhibitor 40  ΝΕΒ 
RNAse H 5  ΝΕΒ 
T4 Polynucleotide Kinase 10 
T4 Polynucleotide 
Kinase Reaction 
Buffer 
ΝΕΒ 
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Kits 
 
RiboPureTM-Yeast Kit (Ambion) 
NucleoSpinTM RNA L Kit (Machery-Nagel) 
 
 
Buffers, Solutions and Media 
 
All buffers, solutions and medias had to be RNAse free. Therefore all stock solutions 
and all media had to autoclaved. Raffinose (10%) and glucose (10%) solutions were 
sterile filtrated. 
If not mentioned otherwise the solution is prepared with ddH2O 
 
 
Cell culture: 
 
YPD-plates:  1 % Yeast Extract 
   2 % Peptone 
   2 % Glucose 
2 % Agar  
55 mg/L Tyrosine 
   55 mg/L Adenine 
 
YPD-media: 1 % Yeast Extract 
   2 % Peptone 
   2 % Glucose  
55 mg/L Tyrosine 
   55 mg/L Adenine 
YPR-media:  1 % Yeast Extract 
 
   2 % Peptone 
   2 % Raffinose  
55 mg Tyrosine 
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   55 mg Adenine 
 
Raffinose and glucose were always added after autoclaving right before 
inoculating. 
 
 
General solutions 
 
1 M Tris pH 7.5 bought from AppliChem 
 
0.5 M EDTA pH 8.0 
pH adjusted with 5 M NaOH 
 
2 M Tris pH 8.0 pH adjusted with HCl (concentrated) 
 
1 M MgCl2    
 
3 M NaOAc pH 5.4 
pH adjusted with acidic acid (concentrated) 
 
Ethanol (p.a.) / 0.3 M NaOAc pH 5.4 
 
10 % SDS (sodium dodecylsulphate, not sterile) 
 
5 M LiCl    
 
1x TBE:  0.089 M TRIS Base 
   0.089 M Boric Acid 
   2 mM  EDTA pH 8.0 
 
Loading buffer: 7 M Urea 
   25 % Sucrose 
   0.25 % Bromphenol Blue 
   0.25 % Xylene Cyanol 
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   in 1x TBE 
 
1 M K-Hepes pH 7.0   
pH adjusted with KOH 
 
3 M KCl    
 
50 % Sucrose 
 
 
DMS-modification 
 
TM-buffer: 10 mM TRIS pH 7.5 
    1 mM MgCl2 
 
 
RNA preparation 
 
AE-buffer:  50 mM NaOAc pH 5.4 
    10 mM EDTA pH 8.0 
 
LETS-buffer: 0.1 M LiCl 
    10 mM EDTA 
    10 mM TRIS pH 7.5 
    0.2 % SDS 
 
Acid-treated glass beads (diameter 0.2 mm) 
 
Phenol pH 4.0, water saturated 
 
CI: Chloroform : Isoamyl alcohol 24:1 
 
PCI: Phenol : CI = 1:1 
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RNA quality control 
 
Agarose gel (1% agarose in 1x TBE) 
 
dNTP mix  10mM dATP 
   10mM dCTP 
   10mM dGTP 
   10mM dTTP 
 
 
Primer purification and kinasing 
 
20 % Acrylamide Solution: 
7 M Urea 
    20 % Acrylamide / Bisacrylamide 19:1 
    in 1x TBE 
 
Elution buffer: 250 mM NaOAc pH 5.4 
   10 mM TRIS pH 7.5 
   2 mM EDTA pH 8.0 
0.1 % SDS 
 
γ-P32-ATP: 6000 Ci/mmol 
 
 
Reverse transcription and subsequent cDNA resolvation 
 
4.5x Hybridisation Buffer:  
225 mM K-Hepes pH 7.0 
   450 mM KCl 
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10x Extension Buffer:  
1.3 TRIS pH 8 
   100 mM MgCl2 
   100 mM DTT 
 
dNTP solution: 2.5 mM dATP 
   2.5 mM dCTP 
   2.5 mM dGTP 
   2.5 mM dTTP 
 
1 mM ddTTP 
 
1 mM ddGTP 
 
1 M NaOH 
 
1 M HCl 
 
Poisoned mix  0.88 mM dATP 
    0.88 mM dGTP 
    0.88 mM dTTP 
    3.68 mM ddCTP 
 
8 % Acrylamide Solution 7 M Urea 
    8 % Acrylamide / Bisacrylamide 19:1 
    in 1x TBE 
 
10 % Ammoniumpersulfate 
 
TEMED   
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Results 
 
General approach 
 
To get structural data for the ai5γ intron in vivo we used dimethyl sulfate to chemically 
probe its structure (Figure 9). DMS penetrates the cell and its compartments quickly 
thereby methylating all accessible N1 of adenosines and N3 of cytosines. Hydrogen 
bonding or binding of a protein abolishes the accessibilities of these nitrogens. After 
RNA preparation modified adenosines and cytosines were identified by reverse 
transcription since attached methyl groups cause the reverse transcriptase to stop the 
extension. As the RNA pool is composed by an ensemble of RNA molecules the 
accessibility to DMS in vivo has to be interpreted as an average value. The cDNA pool 
then was resolved on a denaturing gel revealing all stops caused by DMS modification, 
as they don’t show up in the RT stop control lane. The intensities of the related bands 
directly correlate to the solvent accessibility of the respective nucleotide and these 
results can then be plotted on the secondary structure map. 
 
 
Figure 9: The basic principles of the in vivo DMS chemical probing technique. A) Methylation site of 
adenosine (left) and cytosine (right). B) Only solvent accessible N1 of As and N3 of Cs are methylated. 
C) After RNA preparation reverse transcriptase stops at modified nucleotides. D) The cDNA pool after 
reverse transcription is resolved on a denaturing gel. The first two lanes are sequencing lanes. The third 
lane is showing cDNA derived from cells that were not treated with DMS to reveal all natural stops of the 
RT. The forth lane is showing bands corresponding either to a natural stop, which would also be present 
in the RT stop control lane, or DMS modification 
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Screening for an adequate RNA preparation method 
 
The biggest challenge in the method of in vivo DMS probing is working with RNA 
expressed at endogenous levels. There is no reasonable possibility to get rid of rRNA or 
tRNA, which are the most abundant RNAs in the cell (Figure 12). Furthermore ai5γ is 
located in the mitochondria additionally increasing the importance of a proper RNA 
preparation technique that efficiently lyses cells and their organelles. Besides that the 
quality of the RNA is crucial as the resolution of the final denaturing gel is at single 
nucleotide. Since in the end the intensity of the bands or in other words the band pattern 
has to be interpreted, breaks have to be kept at a minimum. 
In short the RNA preparation had to fulfil following premises: Mitochondria have to be 
efficiently lysed to ensure the highest mtRNA versus cytoplasmatic and nuclear RNA 
ratio. The quality of the RNA has to be very high meaning that degradation and residual 
cellular components have to be kept at a minimum. DNA contamination has to be very 
low. 
The latter is important to use approximately the same amount of ai5γ RNA in reverse 
transcription. 
The different extraction procedures that were initially tested are described in the chapter 
“Methods”. 
 
Growth media 
 
Although preculture yeast cells are typically cultivated in YPD, raffinose as 
carbohydrate source resulted in significantly higher amount of ai5γ RNA although the 
total RNA used was the same, since more mitochondria are produced when using this 
sugar (Figure 10). 
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Figure 10: Choosing carbohydrate 
source. Lane a) Cells were grown in 
YPD. Lane b) Cells were grown in 
YPR. For reverse transcription the 
primer Sc82 was used. Full-length 
product shows significantly higher 
output in YPR as growth media. 
 
 
Total RNA extracted 
 
The different methods varied significantly in the amount of RNA extracted from a cell 
culture with 107 cells (~1ml at an OD600 of 1). Due to the endogenous level of ai5γ 
RNA, a huge amount of RNA was needed for mapping the entire intron. 
The “hot acid phenol” method with an included douncing step to actively disrupt the 
cell wall yielded most RNA with 20 µg per ml cell culture. The least amount of RNA 
was obtained with the NucleoSpinTM Kit (see table 1). 
 
 
DNA contamination 
 
DNA contamination was very prominent in the two “homemade” protocols “Hot acid 
phenol” and “Glass beads”. Actually only the RibopureTM Yeast Kit (Ambion) barely 
showed nuclear or mitochondrial DNA contamination (Figure 11). 
full length 
a b 
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A B 
Figure 11: A) Mitochondrial DNA contamination; 1 – 1 kb DNA ladder (NEB), 2 – RT-PCR of RNA 
prepared with hot acid phenol method, 3 – PCR of RNA prepared with hot acid phenol method showing 
DNA contamination, 4 – RT-PCR of RNA prepared with NucleoSpinTM, 5 – PCR of RNA prepared with 
NucleoSpinTM, 6 - RT-PCR of RNA prepared with RibopureTM, 7 - PCR of RNA prepared with RibopureTM, 
8 – negative control showing PCR without template. B) Nuclear DNA contamination; 1 – PCR of RNA 
prepared with hot acid phenol method, 2 – PCR of RNA prepared with NucleoSpinTM, 3 – PCR of RNA 
prepared with RibopureTM, 4 - positive control with plasmid DNA as template, 5 - negative control showing 
PCR without template, 6 - 1 kb DNA ladder (NEB) 
 
 
RNA quality 
 
RNA quality (figure 12) and signal to noise ratio on the cDNA Polyacrylamid gel 
(figure 13) are directly related making this the most important aspect of RNA 
preparation. The strongest band referring to full-length cDNA using Sc82 and lowest 
hydrolysis background showed RNA prepared with RibopureTM Yeast Kit. Least quality 
produced NucleoSpinTM (Figures 12 and 13). 
1 2 3 4 5 6 8 1 2 3 4 5 7 6 
440 nt 
1995 nt 
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Figure 12: Agarose gel showing RNA quality of the different RNA 
preparation methods. 1 – hot phenol method, 2 – glass bead method, 3 - 
NucleoSpinTM, 4 - RibopureTM 
 
 
 
 
 
Figure 13: Representative gel showing signal to noise ratio of different preparation 
methods. Also mitochondrial lysis efficiency is shown by the amount of full length. 
RNA was prepared with 1 – RibopureTM, 2 – glass bead method, 3 – hot acid phenol 
method, 4 - NucleoSpinTM  
full length 
1 2 3 4 
1 2 3 4 
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Efficiency of mitochondrial lysis 
 
This could be seen in the amount of full-length cDNA after reverse transcription (Figure 
13), since the same amount of RNA is used in reverse transcription. Here both kits used 
were significantly more efficient than the homemade protocols. 
 
 
Summary 
 
Comparing all the tested features the RibopureTM Yeast Kit was by far showing the best 
results (table 1). 
Method 
RNA (µg) per 
107 cells 
(average 
 
DNA 
contamination 
RNA 
quality 
Efficiency of 
mitochondrial 
lysis  
Hot Acid Phenol 10 n.d n.d n.d 
Hot Acid Phenol* 20 +++ ++ + 
Glass bead 10 ++ ++ + 
Glass bead** 6 n.d n.d n.d 
NucleoSpin 
(Machery-Nagel) 
3.5 + + ++ 
RiboPure Yeast 
(Ambion) 
7 + +++ +++ 
Table 1: Summary of the different features of RNA that were important for the applied in vivo chemical 
probing assay. * douncer step was included, ** hot acid phenol treatment in beginning, n.d. – not 
determined 
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Determining the optimal DMS concentration   
 
Since the actual experiment in chemical probing of ai5γ in vivo is DMS modification, 
this step is crucial for the quality of data obtained in the end. Here the amount of DMS 
should lead to maximum one modification per RNA molecule. To find the optimal 
concentration of DMS we carried out a concentration series starting with 0 and ending 
with 150 mM DMS. Additionally we performed a stop control to check efficient 
quenching of DMS by β-mercaptoethanol (Figure 14). 
Comparing lane 3 with lane 4-7 shows that 50 mM of DMS is optimal, as it shows a 
comparable same amount of full-length cDNA and still has a good signal to noise ratio. 
In the stop control lane no modification is seen indicating that the used amount of β-
mercaptoethanol is sufficient to quench the DMS molecules. 
 
 
Figure 14: Gel for determining DMS-concentration and proper quenching. A) Lanes 1 and 2 show 
sequencing for adenosine and cytosine, in lane three cells were not treated with DMS, lanes 4 to 7 show 
cells treated with an increasing amount of DMS starting with 25 mM ending with 150 mM, in lane 8 the 
quenching reagent β-mercaptoethanol was added before DMS. Residues 46 to 108 are not shown. B) 
Secondary structure map showing the modification pattern represented by lane 5 (50 mM DMS). The size 
of the gray dots corresponds to the relative modification intensity. 
 
A B 
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Ai5γ splices efficiently in vivo in the presence of 
Mss116p 
 
In the poisoned primer assay reverse transcriptase has only three nucleotides in their 
deoxy form available. Instead of dCTP ddCTP is added as the fourth nucleotide. This 
terminates the extension of the Sc-6 primer either after 8 nucleotides if the intron is still 
integrated (pre-RNA) or after 14 nucleotides if the intron is spliced (mRNA) (figure 
14). With this in vivo splicing assay spliced mRNA and unspliced precursor RNA can 
be detected and the splicing efficiency of ai5γ in the respective strain can be determined. 
70 % of the intron is spliced in the wild type strain. In the knock out strain, though, less 
than 0,5% of the intron has been spliced a signal that is not significantly more intense 
than noise (figure 15). Additionally DMS treatment does not interfere with the splicing 
efficiency as seen by comparing the splicing ratio of untreated and treated cells (data not 
shown). 
 
Figure 14: Poisoned primer assay. 
Pre-RNA and mRNA are shown 
schematically including the first G 
after primer binding site. 
 
 
 
Figure 15: In vivo splicing assay. Spliced (mRNA) and 
unspliced (pre-RNA) products are shown. While ~ 75 % of the 
intron is spliced in the wild type strain splicing is completely 
abolished in the knock out strain 
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The intracellular structure of ai5γ 
 
The secondary structure of group II introns has been predicted early by phylogenetic 
studies (Michel et al. 1989). There is no high resolution tertiary structure available for 
ai5γ but a 3D-Modell is partly available due to identified tertiary contacts and surface 
solvent accessibility data (Costa and Michel 1995, Costa et al. 1997, Boudvillain and 
Pyle 1998, Boudvillain et al. 2000, Fedorova and Pyle 2005, Michel and Ferat 1995, 
Swisher et al. 2001). 
As described before ai5γ folds into its native structure at elevated temperature and high 
salt conditions (Su et al. 2003, Swisher et al. 2001). Both parameters are not available in 
the cellular mitochondria, were folding of ai5γ takes place. To get more insight into the 
intracellular structure of ai5γ we therefore applied the in vivo DMS chemical probing 
technique (Liebeg and Waldsich 2009). To map the whole intron 13 primers were used 
(see materials). 
 
The most critical intron domains adopt their proper secondary 
structure in vivo 
 
In this chapter I will discuss DMS modification data according to the secondary 
structure of ai5γ in vivo. Nucleotides that are not protected by taking part in secondary 
structure elements but by being involved in tertiary interactions will be discussed later. 
The asymmetrical internal loop at the stem i of D1 is accessible to DMS showing strong 
modification of A11, A12, A13 (figure 16) and A411 (figure 17). The i-stem itself is 
formed since all N1 of adenosines and N3 of cytosines involved are protected from 
methylation by Watson Crick base pairing. Stem a is closed with the adenosines in the 
heptaloop accessible to DMS. Some N1 of adenosines are weakly modified in stem b 
(A66, A67 and A69; figure 16), suggesting that while the secondary structure in this 
region is established in some molecules of the ensemble it isn’t. The c1 stem has 
adapted its native conformation due to the DMS pattern observed. As expected from the 
proposed secondary structure A92, A93, and A94 are accessible since located in an 
internal asymmetrical loop (figure 16). Unexpectedly A105, which should not be 
involved in base pairing, did only show weak modification below the threshold (figure 
16). This points to a non-canonical base-pair interaction. The strong modification of 
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A114, which is part of a 4-nucleotide bulge, then again fits to the proposed secondary 
structure model (figure 16); A115 and A117 are involved in tertiary interactions and 
will therefore be discussed later. In the c-c1-c2 3-way junction A125, C126, A127 and  
A128 that were shown to be important for the collapse of the ai5γ ribozyme D135 in 
vitro (Waldsich and Pyle 2007) are accessible in ai5γ in vivo (figure 16). Stem c2 is 
consistent with the secondary structure in its DMS modification pattern except for 
A157, A162 and A164-166 that show weak to moderate modification intensities 
although proposed to be present in a helical conformation (figure 16). Maybe this helix 
 
 
 
 
 
 
Figure 16: Representive gels for DMS pattern of ai5γ in wild type cells. Reference nucleotides are 
indicated on the left. Lane A and C are sequencing lanes for adenosine and cytosine. Lane – 
corresponds to wild type cells that were not treated with DMS, lane + to DMS treated wt cells. On the 
right modified nucleotides are shown. The size of arrows corresponds to intensity of modification 
(weak, moderate, strong). A) Nts C4 to A78. B) Nts A84 to A148. C) Nts A159 to A225. 
A B C 
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is not very stable since it is only short and exclusively involving A-U base pairs (Tinoco 
et al 1971) suggesting that this helix is only formed in a fraction of the RNA pool. 
Nevertheless both internal loops show reasonable modification intensities to allow the 
assumption that the secondary structure of stems c c1 c2 is established. The same can be 
said for stem d, where no modification is taking place. A208,  
A209 and A210 that are part of a tetraloop at the κ element show strong modification as 
expected (figure 16). Furthermore adenosines and cytosines located in d’, d’’, d’’’, d2a, 
d2b and d3 are not methylated by DMS. A225, A227, A229 (figure 17, strong 
modification) and A368 (figure 17, moderate modification) that are involved in 
asymmetrical internal loop between d’’ and d’’’ are modified by DMS indicating the 
proper folding of this loop that binds the bulged A880 (Hamill and Pyle 2006) and is 
also called “coordination loop” as it was proposed to align all reaction components 
necessary for splicing (DeLancestre et al. 2005). Unmodified A228 and A370 might in 
this context be involved in tertiary interactions. Nucleotides of the 4-way junction 
 
 
 
 
 
 
 
 
 
 
Figure 17: Representive gels for DMS pattern of ai5γ in wild type cells. Legend as Figure 16. A) Nts 
C217 to A290. B) Nts A289 to A368. C) Nts A368 to A429. 
A B C 
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between d’’’, d2a, d2b and d3 are modified weakly (A237, A239 and A242), 
moderately (A238, C240 and C241) or strongly (C243) indicating that this loop has 
formed properly and that exons are not bound (figure 17). A289 and A290 that are part 
of the tetraloop in d2b are modified strongly (figure 17). A326, A331-333 and A336 
being located in a terminal loop and the bulged A353 are modified (figure 17). 
Interestingly A351, which should be involved in Watson-Crick base pairing, is strongly 
modified indicating a non-canonical base-pair interaction at this nucleotide (figure 17). 
In D3 nucleotides involved in a, b and c stems are protected from modification. As 
A636 in the tretraloop of stem b and A651-653 in the tetraloop of the c stem are 
moderately accessible to DMS N1 of this adenosines are not involved in any 
interactions (figure 18). The asymmetrical internal loop at the basal stem of D3 is 
present due to modifications of A597, A598, A599, A662 and C663 (figure 18 and 19). 
In D5 the only significant high modifaction could be seen at A838 that is part of the 
 
 
 
 
 
 
 
 
 
Figure 18: Representive gels for DMS pattern of ai5γ in wild type cells. Legend as Figure 16. A) Nts 
C422 to A512. B) Nts A521 to A579. C) Nts A573 to A646. 
A B C 
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important dinucleotide bulge showing that D5 adopts its structure in vivo (figure 19). 
C839 is involved in a tertiary interaction and therefore discussed later. 
An interesting phenomenon in general can be seen at some nucleotides at the ends of 
several stems, e.g. A128 (figure 16), A420 (figure 17), A308 (figure 17) or A630 (figure 
18) since they show moderate or even strong modification intensities. This actually 
hints to a non-canonical base pair interaction like a reverse Hoogsteen A.U pair or might 
also be explained by breathing of terminal base pairs in duplexes. 
 
 
D2 adopts a different structure in vivo 
 
In D2 the helix harbouring the important docking site η for D6 is formed properly. 
Furthermore all loops are present as shown by the modifications of A560-562, A526-
528, A523-525, A521, A498, A496, A448-A453 and A444-445 (figure 18). 
Interestingly A501, A502 and A503-A507 are modified as well although they should be 
 
 
 
 
 
 
 
 
Figure 19: Representive gels for 
DMS pattern of ai5γ in wild type 
cells. Legend as Figure 16. A) 
Nts C663 to A738. B) Nts A789 
to A842. 
A B 
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involved in a helix according to the predicted secondary structure (figure 20). This 
could only be explained by a different structure in this region of D2. 
 
In vivo structure of D4 
 
The structure of D4 in ai5γ has not been determined until know. Therefore we applied 
our in  
vivo DMS chemical probing assay to get further insights into the structure of D4. Doing 
this in combination with the RNA folding program mfold (Zuker 2003) we found a 
possible and consistent secondary structure for D4 presented in Figure 20. In this 
scheme the basal stem participates in a 4-way junction. The other protruding stems are 
closed by loops with nucleotides accessible to DMS (A713, A751, A753, A755) except 
for A780 that might be involved in tertiary or non-canonical interactions (figure 19, gel 
showing A751, A753 and A755 not shown). The largest stem has an additional internal 
asymmetrical loop (A698, A700, A702, A722-730) and a bulged A692 (figure 19, gel 
showing A22-730 not shown). 
DMS modification data on D6 is not available since it is the first possible binding site 
for primers. 
To conclude, the DMS modification data on ai5γ in vivo (figure 20) correlates well with 
structural probing data derived from ribozymes in vitro (Fedorova et al. 2007, Swisher 
et al. 2001, Su et al. 2005) and the phylogenetically derived secondary structure map 
(Michel et al. 1989). This indicates that ai5γ adopts its native structure in vivo and that 
this native structure strongly resembles the structure ai5γ adopts under high salt 
conditions and elevated temperature in vitro. 
 
 
Long-range tertiary interactions are in place in vivo 
 
As ai5γ is very compact in its native conformation (Swisher et al. 2001) the network of 
long-range tertiary interactions plays a crucial role in establishing the catalytically 
active structure of this ribozyme. 
Concluding from the DMS pattern the D1 intra-domain α−α’ contact, which is 
inevitable for exon binding and compaction (Su 2002, Waldsich and Pyle 2007) is 
established in vivo. A63 and C65 that are found in the α region are only weakly 
 54 
modified (figure 16) and A344 as well as A346-348 in the α’ element lack modification 
(figure 17). Likewise the intra-domain β−β’ interaction is present in vivo although as in 
the α−α' contact A146, C147 and A148 in the β region show weak modification 
intensities (figure 16) whereas C255 and C259 in the β’ region don’t (figure 17). Both 
phenomenons might be a result of the fact that we are always looking at a population of 
RNA molecules with a significant amount of unspliced ai5γ of about 25%. Furthermore 
the β−β’ interaction is not phylogenetically conserved (Michel and Ferat 1995) and 
dispensable for its catalytic activity in vitro (Su 2002). 
Besides the D1 intra-domain long-range tertiary interactions are in place as well. A100 
and A101 show no modification (figure 16) indicating that the θ−θ’ interaction between 
the c1 tetraloop and the basal stem of D2 is established (Costa et al. 1997). This 
interaction brings stem c1 with its λ and ε’ regions close to the essential joining element 
J2/3 (Fedorova et al. 2003). Furthermore establishment of the helix in D2 harboring the 
η region, as seen by lacking modifications of C464-465 and A466-467 (figure 20), 
suggests that the η−η’ tertiary interactions between D2 and D6 is present bringing the 
branch point A880 close to the active site (Chanfreau and Jacquier 1996, Costa et al. 
1997, Hamill and Pyle 2006). Also the coordination loop, which is the binding site for 
A880, is formed properly in vivo, due to its modification pattern (figure 20). 
In short it seems that the network of long-range tertiary interactions necessary for 
establishing the compact native structure of ai5γ are in place. 
 
 
The active site of the spliced ai5γ remains assembled 
 
In a wt yeast strain the ai5γ group II intron splices efficiently with approximately 70 % 
of the entire population spliced. This means that in the wild type strain the DMS 
modification pattern observed mainly evolves from the structure of the spliced intron. 
Consistent with this are the modifications of nucleotides found at the exon binding sites 
EBS2 (A237, C238, A239, C240, C241, A242, and C243) and EBS1 (A331-A333) 
indicating that the exon substrates are no longer bound (figure 17). 
Intriguingly the catalytic centre of the intron seems to remain established in the spliced 
intron. The ζ−ζ’ interaction is in place indicated by the distinct modification intensities 
of A382 and A383 (figure 17) that are forming an A.A platform suggesting a canonical 
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form of this receptor (Cate et al. 1996). The weak modification of A198 (figure 16) 
pairing with U381 and of A830 and A832 (figure 19) suggests that most of the ai5γ 
molecules have their ζ−ζ’ interaction between D1 and D5 established. Additionally 
A204 lacks modification and A214-215 are only weakly modified (figure 16) meaning 
that also the κ−κ’ contact is present in the spliced intron in vivo. This indicates that the 
catalytic domain D5 is anchored in its receptor site in D1, which is a pre-requisite for 
active site formation. Further evidence for active site assembly could be seen in the 
established λ−λ’ and ε−ε’ interactions: C117 is not accessible to DMS (figure 16), 
which is in line with interactions of C117-N3 with G3-N3 (Boudvillain and Pyle 1998). 
Weak modification of A115 indicates that the base triple interaction named λ−λ’ with 
the Watson-Crick base pair G825-G836 is present (figure 16). In analogy to the crystal 
structure of the O. iheyensis group II intron (Toor et al. 2008) C839, G588, A589 and 
the catalytic triad A816, G817 and C818 could be involved in a triple helix. The minor 
modification of A589 (figure 18) and C839 (figure19) hints to established base triples 
with A816-U847 and C818-G845, respectively. As A587 is also only modified in a 
minor way (figure 18) the interaction between this nucleotide in J2/3 and U887 at the 
very 3’ end of the intron seems to be established. The catalytic effector D3 has two 
important regions considering tertiary interaction. A617-618 are only weakly modified 
(figure 18) implying an established µ−µ’ contact with the 2’OH of G844 in D5 
(Fedorova and Pyle 2005). The second important region is the internal loop at the basal 
stem of D3. There two consecutive A.A base pairs are needed for enhancing catalysis 
(Fedorova and Pyle 2005). The Hoogsteen face (N6, N7) of A599 and A662 is thereby 
H-bonding with the minor groove edge (C2, N3, 2’OH) of A661 and A598. 
Furthermore this region is contacting the ε−ε’ region and energetically communicating 
with the dinucleotide bulge in D5 (Fedorova and Pyle 2005). Interestingly this 
conformation is not maintained in the spliced intron in vivo as A597, A598 and C663 
were all equally modified by DMS at medium intensity (figure 18). Alternatively, in 
vivo interaction between D1 and D3 happens differently or is abolished after splicing. 
Except from this small difference in the conformation of D3 the structure of ai5γ in vivo 
(figure 20) is very similar to the one observed in vitro (figure 27). Therefore these data 
suggests that the spliced intron maintains its native structure after splicing and that the 
active site remains assembled, which would be important for group II introns that are 
able to act as mobile genetic elements and perform reverse splicing (Pyle and 
Lambowitz 2006). 
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Figure 27: DMS modifications of the ai5γ derived ribozyme D123456. DMS modifications were plotted 
according to their intensities (weak, moderate, large) on the secondary structure map of ai5γ. A) D1, D3, 
D5 and D6 are shown. D6 is in grey since it couldn’t be mapped with this method. B) D2 is shown. C) D4 
is shown. Data kindly provided by Dr. Oliver Mayer.  
 
A 
B C 
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Figure 20: DMS modifications of ai5γ in wild type cells. DMS modifications were plotted according to 
their intensities (weak, moderate, large) on the secondary structure map of ai5γ. A) D1, D3, D5 and D6 
are shown. D6 is in grey since it couldn’t be mapped with this method. B) D2 is shown. C) D4 is shown 
A 
B C 
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Mss116p is not bound to the spliced intron 
 
DMS can modify N1 of adenosine and N3 of cytosine if they are solvent accessible. 
Binding of a protein would render a stretch of nucleotides inaccessible to DMS. By 
comparing the DMS pattern obtained in vivo and in vitro we could not find such a 
footprint for Mss116p on the most important domains D1, D3, D5 and D6. As other 
group II intron cofactors where shown to bind in D4 (Pyle and Lambowitz 2006) we 
focused on that region of ai5γ. But neither did we find a footprint on D4 nor on D2. This 
result implies that Mss116p does not remain bound to the spliced intron in its native 
conformation. Since with the method applied we can only survey N1 of adenosines and 
N3 cytosines it still remains possible that Mss116p binds to other functional groups or 
nucleotides. However, binding of a large protein should at least result in reduced 
accessibility of the respective nucleotides resulting in reduced intensities of DMS 
modifications. We were not able to make such an observation. A second alternative 
reason might be a high koff of Mss116p resulting in only transient binding making it 
impossible to monitor. This is also very unlikely since in vitro Mss116p binds very 
tightly to ai5γ with a KD around 1nM (Halls et al. 2006). As a consequence we conclude 
that Mss116p is not bound to ai5γ in its native state and hence not important for 
maintaining the native conformation of this group II intron. 
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The κ−ζ folding control element cannot adopt its 
structure in the absence of Mss116p 
 
Formation of the κ−ζ element is crucial for the tertiary collapse of the ai5γ derived 
ribozyme D135 in vitro (Waldsich and Pyle 2008) and thereby the rate limiting step. 
Additionally it plays an important role for active site formation during later stages of 
folding. 
The importance of this element drew our attention to specific structural differences of 
this region between the wild type and the knock out strain. As expected the κ−ζ element 
is not formed in absence of Mss116p. Most of the strongest differences in intensity of 
DMS modification are found in this region of the intron. In vitro the formation of d, d’ 
 
 
 
 
Figure 21: Different DMS modifications intensities of ai5γ in wild type and ∆Mss116 cells at the κ−ζ 
element. Differences in DMS modification intensities are indicated according to their intensities. Red 
filled arrows show >2x intensity in the mutant strain compared to wild type, red open arrows <0.5x 
intensity. Grey filled arrows show >1.5x intensity in the mutant strain compared to wild type, grey open 
arrows <2/3x intensity. A) Nts from A177 to A225. B)Nts from A368 to 429. 
A B 
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and d’’ are Mg2+ dependent. All three helices do not form in the knock out strain shown 
by DMS modification of A195, A196, A387 and 389 in d, of A378 in d’’ and of C217, 
A218-A220 and A376 in d’’ (figure 21). Enhanced modification of A204 and A214-
A215 hints to lacking formation of the κ−κ’ contact with D5 (figure 21). Furthermore 
A198 as well as A382 are significantly more modified in the knock out strain (figure 
21) showing that also the ζ−ζ’ interaction is not in place, which is strengthened by the 
enhanced modification of A830-A832 in the D5 tetraloop (figure 24). The explanation 
for these enhancements is that D1 is not docked onto D5 and because of that the active 
site is not established in the knock out strain. In accordance with that A115 and C117 
are more accessible to DMS (figure 22) indicating that the active site constituents ε−ε’ 
and λ−λ’ are not formed. The reduced accessibility of A114 in the knock out strain 
(figure 22) is a result from the lacking λ−λ’ contact that leads to a twist of A114 
pushing its N1 outside. These observations clearly show that Mss116p is essential for 
the formation of the κ−ζ folding control element. 
 
 
Mss116p acts on both secondary and tertiary structure 
formation 
 
As the folding control element in D1 of ai5γ triggers a cascade of folding steps in the 
D135 ribozyme in vitro (Waldsich and Pyle 2007 and 2008) we were interested in the 
effects of the absent cofactor Mss116 on the secondary as well as the tertiary structure 
level. 
Both D1 intradomain contacts α−α’ and β−β’ are not established as the involved 
observable nucleotides A63 (α), A344 and A346-348 (α’), A146, C147 and A148 (β) as 
well as C259 (β’) are significantly more modified (figure 22 and 23) in the knock out 
strain. Interdomain tertiary contacts are affected to a similar extent. Enhanced 
modification of A100 and A101 (figure 22) indicates that the θ−θ’ contact, that brings 
the c1 stem harbouring the ε’ and λ regions close to the basal stem of D2 and the joining 
segment J2/3, is not in place. As the helix in D2 that includes the η element is not  
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formed in the knock out strain indicated by enhanced modification of C464-C465 and 
A466-A467 (figure 23) the η−η’ contact that docks D6 onto D2 bringing the branch 
point adenosines in close proximity to the active site. In line with this, A868-A869 in 
the η’-tetraloop is accessible to DMS in the knock out strain (figure 24), where an exon 
binding primer can be used to map this region. Nucleotides (A227-A229, A386 and 
A370; figure 22 and 23) that are part of the coordination loop, which coordinates A880 
(Hamill et al. 2006), are significantly more intensely modified showing again that the 
active site is not formed in the knock out strain. As A617 and A618 are more accessible 
to DMS in the D3 pentaloop the µ-µ’ interaction that docks D3 in the  
 
 
 
 
 
 
 
 
 
 
Figure 22: Different DMS modifications intensities of ai5γ in wild type and ∆Mss116 cells. Legend as 
Figure 21. A) Nts C4 to A78. B) Nts A84 to A148. C) Nts A217 to A290. 
A B C 
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active site is not established (figure 23). Finally J2/3 (A484-A486) that forms a triple 
helix with the catalytic triad (Toor et al. 2008) in D5 shows enhanced modification 
(figure 23). Taken together all tertiary contacts seem to be open in the knock out strain 
according to their DMS. These findings imply that neither the active site is formed nor 
the compact conformation of ai5γ obtained when Mss116p is not present as a cofactor. 
The effects off absent Mss116p on the tertiary structure of ai5γ were expected although 
the extent wasn’t. The consequences for the secondary structure of the group II intron in 
vivo were more surprising. Aside from the already mentioned stems d, d’, d’’ also the 
helices d’’’, a, c and i of D1 are not formed in the knock out strain revealed by enhanced 
modification of e.g. A22-24, C408, A411-A412 and A399 (i), A50-A52 (a), A72, A187 
 
 
 
 
 
 
 
 
 
Figure 23: Different DMS modifications intensities of ai5γ in wild type and ∆Mss116 cells. Legend as 
Figure 21. A) Nts A289 to A371 B) Nts A441 to A512. C) Nts A573 to A646. 
A B C 
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and C188 (c) and A230 as well as A365-A366 (d’’’) (figure 21, 22 and 23). 
Interestingly except for stem i all these helices need Mg2+ in vitro to be formed 
(Waldsich and Pyle 2007) implying that the secondary structure of ai5γ in the knock out  
strain resembles the in vitro one in presence of K+ ions but without Mg2+ added 
(Waldsich and Pyle 2007). Additionally to D1 the secondary structure of D3 is affected 
in the ∆mss116 strain. Here, the basal stem (A594 and A596-A597) and the internal 
loop (A598-A560) as well as stem b (A630, A632-A633, A639 and C642) are not 
formed properly due to enhanced accessibility of the mentioned nucleotides (figure 23). 
Actually the unfolded state in vitro contains more secondary structure elements than the 
unspliced intron in vivo in the absence of Mss116p (figure 25, Waldsich and Pyle 2008). 
 
 
 
 
 
 
 
 
 
Figure 24: Different DMS modifications intensities of ai5γ in wild type and ∆Mss116 cells. Legend as 
Figure 21. Green arrows in B show modifications in the mutant strains at positions that are not expected 
to be accessible in the wild type strain, which couldn’t be primed due to splicing A) Nts C663 to 
A738.B) Nts A816 to A842. C) Nts A853 to A880 
A B C 
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This could be explained by the nonphysiological concentration of monovalent ions 
applied to get the unfolded state of ai5γ where most of the secondary structure elements 
are present. 
In D2 only the helix that contains the η element shows strong enhancement by the 
absence of Mss116p (figure 24). Likewise in D4 only A801-A803 show enhanced 
modification intensities in the ∆mss116 strain (gel not shown). This suggests that 
Mss116p plays a minor role in the structural organisation of D2 and D4. Also secondary 
structure formation of D5 and D6 seems independent of Mss116p. Therefore Mss116p 
seems to act mostly on the D1 scaffold and the effector D3 as well as tertiary contacts. 
In the knock out strain these regions are unstable suggesting that Mss116p acts by 
stabilizing ai5γ. Since we did not see a stretch of residues being more structured in the 
knock out strain kinetic traps seem not to occur in the absence of Mss116p.  
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Figure 25: Different DMS modifications intensities of ai5γ in wild type and ∆Mss116 cells. Differences in 
DMS modification intensities were plotted according to their intensities on the secondary structure map of 
ai5γ. Colour code as in figure 21. A) D1, D3, D5 and D6 are shown. D6 is in grey since it could only be 
mapped in the mutant strain. B) D2 is shown. C) D4 is shown 
A 
B C 
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Discussion 
 
 
After transcription catalytic RNA has to adopt a specific structure in order to fulfil its 
function. Folding into this structure is fundamental and in general a complex process. 
Folding has been studied intensely in vitro and little is known about this process in vivo 
where folding happens co-transcriptionally (Schroeder et al. 2002). Ribozymes derived 
from the group II intron ai5γ in S. cerevisiae have proven to be a good model system for 
the folding of large RNAs (Pyle et al. 2007). But there have been only few attempts to 
compare folding of RNA in vitro and in vivo.  
 
 
The intracellular structure of ai5γ 
 
During my diploma research I first had a look at the intracellular structure of ai5γ to 
compare it with data gained in in vitro studies. 
To do that we applied the described in vivo DMS chemical probing assay (see Methods) 
to obtain structural information both on secondary and tertiary structure. We found out 
that the intracellular structure vastly resembles the structure of D123456 in vitro despite 
of the very different folding environment. In vivo ai5γ adopts its secondary structure. 
Also all inter- and intradomain tertiary contacts are in place and most importantly the 
active site is properly assembled. Indeed most of the ai5γ RNA molecules are spliced. 
Interestingly the intron keeps its native conformation after splicing. Recently it was 
shown that the ai5γ group II intron is able to perform reverse splicing (Roitzsch and 
pyle 2009). The data of this thesis suggests that this group II intron does not have to 
undergo major structural rearrangements for its ability to reverse splice. This might be 
important for other group II introns that are in contrast to ai5g not only able to reverse 
splice but also known to act as mobile genetic elements in assistance of a self-encoded 
maturase (Pyle and Lambowitz 2006). 
 
 
 67 
The function of Mss116p in ai5γ folding  
 
Folding of ai5γ-derived ribozymes has been studied intensely in vitro both at non-
physiological conditions with elevated temperature and high K+ and Mg2+ levels (Su et 
al. 2003, Swisher et al. 2001, Waldsich and Pyle 2007) and at near-physiological levels 
(Fedorova et al. 2007). Interestingly ai5γ collapses to the compact intermediate in vitro 
even at near-physiological conditions but complete compaction takes 26 h, which is 
tremendous considering the needs of a living cell (Fedorova et al. 2007). Furthermore 
the native state can only be approached in vivo at physiological temperatures when 
[Mg2+] is raised to 100mM. However adding of the DEAD box protein Mss116p in vitro 
lowers the needed [Mg2+] to a near-physiological level for native state conformation 
(Halls et al. 2006, DelCampo et al. 2007, Solem et al. 2006). Furthermore it was shown 
that Mss116p is essential for splicing of ai5γ in vivo (Huang et al 2005). It was proposed 
that Mss116p acts as a RNA chaperone that actively disrupts kinetically trapped 
molecules allowing them folding into the native state (DelCampo et al. 2007). However 
previous studies showed that the unwinding activity of Mss116p is not essential for 
splicing activity of ai5γ (Solem et al. 06). Additionally to ai5γ efficient splicing of all 
mitochondrial group I and II introns in yeast depends on Mss116p (Huang et al. 2005). 
Furthermore the family of DEAD box proteins is found in almost all cellular processes 
involving RNA structural organisation (Cordin et al. 2006). Although there has been 
quite an effort and success in understanding the functions of DEAD-box proteins, it is 
still enigmatic how folding of large RNAs can be facilitated by non-processive DEAD-
box helicases. We wanted to know how one of those proteins, Mss116p assists in 
folding of ai5γ in vivo. 
To do that we applied the mentioned in vivo chemical probing assay additionally on a 
strain where mss116 was knocked out. The first striking result was the extent of impact 
Mss116p has on the structure of ai5γ. Without its assistance not only that none of the 
intra- or interdomain interactions are in place but even more intriguingly the entire 
intron is largely unfolded. This indicates that Mss116p acts at a very early stage of 
folding since the secondary structure is severely perturbed. In context with that it is 
noteworthy that only a few nucleotides showed protection from methylation in the 
knock out strain compared to the wild type strain and that these nucleotides where all 
standing alone hinting to a different conformation of this one nucleotide. A stretch of 
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protection indicating misfolding of ai5γ in the knock out strain was not found. Instead 
especially the scaffold D1 seems to be inherently unstable without Mss116p assisting. 
This is also consistent with the almost total loss of splicing activity in the knock out 
strain (<1%) as the native structure cannot be obtained and the active site not 
assembled. Therefore we propose that Mss116p acts on ai5γ folding by stabilizing on 
pathway intermediates instead of resolving misfolded structures. This is also in good 
agreement with the unimportance of the unwinding activity of Mss116p for splicing of 
ai5γ in vitro (Solem et al. 2006). Since D1 also folds first in vitro and was proposed as a 
folding scaffold (Su et al. 2005) acting of Mss116p on this structurally most relevant 
domain makes absolute sense. Additionally in vivo folding happens co-transcriptionally. 
By having Mss116p acting on D1 folding can immediately take place, which of course 
is favourable in an evolutionary point of view. 
 
 
In vivo folding pathway 
 
With this data present and having the knowledge from previous experiments dealing 
with the folding pathway of ai5γ in vitro (Pyle et al. 2007, Steiner et al. 2008) it is 
possible to describe an in vivo folding pathway of this group II intron. Pyle and co-
workers revealed that the ai5γ group II ribozyme D135 is following a direct path to its 
native structure where the formation of the scaffold D1 is the prerequisite for the 
collapse of the intron into a compact intermediate (Su et al. 2005). This first step of 
tertiary folding is unusually slow with a rate constant of ~1 min-1. It is noteworthy that 
the starting point of this experiment was an electrostatically relaxed state of the 
molecule by adding monovalent ions. The relaxed molecule however did not show any 
tertiary fold although significant compaction indicated formation of secondary structure 
elements (Su 05). The collapse itself is controlled by the Mg2+ dependent formation of a 
small substructure within D1 the κ−ζ folding control element (Waldsich and Pyle 2007 
and 2008). Interestingly this same element plays a crucial role in active site assembly 
later on (Boudvillain and Pyle 1998, Costa et al. 1995). Introducing a component of the 
active site as a control element for folding is a sophisticated way to ensure proper 
folding of the core region of ai5γ. Folding from the intermediate state to its native 
conformation then happens fast. Another astonishing feature of the folding pathway of 
ai5γ in vitro is the lack of kinetic traps (Swisher et al. 2002, Steiner et al 2008). 
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Furthermore it has been shown that substrate binding stabilizes the compact 
intermediate (Steiner et al. 2008). 
The biological relevance of this folding pathway for ai5γ in its actual intracellular 
environment was still to be confirmed as needed [Mg²+] for folding in vitro are not 
present in vivo. In our study we first of all saw that the intracellular cofactor, known to 
be essential for splicing of all group II introns, Mss116p was not bound to the intron in 
its native conformation, as it did not show any footprint. In light of the in vitro folding 
pathway and together with the largely unfolded structure in the knock out strain this 
indicates that Mss116p acts at an early stage of ai5γ folding and is not required to 
maintain the active native structure of the intron. As in the knock out strain the strongest 
enhancements of modification are found in the folding scaffold D1, Mss116p seems to 
assist in the transition of the unfolded intron to the compact intermediate where D1 has 
adapted its structure. Since the folding control element is severely disturbed in its 
structure without Mss116p present, the cofactor might act on this small element. 
Subsequent docking of the other domains for active site assembly then needs Mss116p 
to release the intron to allow tertiary interactions. Interestingly formation of the k-z 
element is dependent on Mg2+, which proposes possible similarities in functions of 
Mss116p and magnesium. Therefore Mss116p might act by stabilizing RNA structure 
and in our case by actually stabilizing the proper structure of the κ−ζ folding control 
element. Furthermore it was shown that in contrast to unwinding activity ATPase 
activity of Mss116p is absolutely required for splicing activity of ai5γ both in vitro 
(Solem et al. 2006) and in vivo (Mohr et al. 2006). As ATPase activity causes structural 
changes in DEAD box proteins, this might allow the release of the cofactor rendering 
docking of the catalytic center D5 and of other domains possible. To summarize the 
data from this diploma thesis suggests the following folding pathway in vivo (figure 26): 
 
Figure 26: Schematic of proposed role of Mss116p in ai5γ folding. Mss116p binding allows collapse of ai5γ. 
In order to allow folding into native structure Mss116p has to be released. 
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Mss116p perhaps stabilizes the formation of the κ−ζ element found in D1. After D1 has 
properly formed ATPase activity ensures release of the cofactor. Exon binding stabilizes 
the formed compact intermediate maintaining the structure without further assistance by 
Mss116p. With the folding control element and D1 present subsequent docking of the 
other domains and active site assembly in short native structure formation is fast. The 
resulting native structure is stable in vivo without binding of Mss116p rendering ai5γ 
splicing-competent. 
 
 
Mss116p is a multifunctional enzyme 
 
Previously it was suggested that Mss116p and DEAD box proteins in general act as 
RNA chaperones that actively disrupt misfolded structures allowing native structure 
formation (Mohr et al. 2006, Halls et al. 2007, Delcampo et al. 2007). It was shown that 
Mss116p shows unwinding activity in vitro (Solem et al. 2006, Delcampo et al. 2007). 
Furthermore Mss116p functions in RNA processing and translation in yeast 
mitochondria (Huang 2004). As the latter ones only hint to more functions of the same 
protein the unwinding and stabilizing activity are somehow contradictory. Intriguingly 
only a subset of DEAD box proteins where shown to be able to rescue splicing activity 
of ai5γ in vitro (Solem et al 2006) and in vivo (Mohr et al. 2006). The speciality of these 
proteins is a distinct C-terminal domain that is arginine rich. Therefore the stabilizing 
function of helicases might be evolutionary younger than the unwinding activity and 
have evolved at this distinct C-terminal domain. Mss116p also acts on all mitochondrial 
group I and II introns suggesting different mode of action as a cofactor. For example the 
folding intermediate of the bI5 group I intron is stabilized by CBP2 in vitro (Weeks and 
Cech 1996). Thus Mss116p might act differently on this RNA. 
Having a multifunctional enzyme present in mitochondria is definitely a worthy strategy 
from an evolutionary point of view since a lot of energy can be saved in transcription, 
translation and mitochondrial import. 
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Perspectives 
 
The findings of this diploma thesis evoke a lot of further questions. Seeing that 
Mss116p acts by stabilizing RNA structure makes one wonder how it actually does that. 
Our findings that the κ−ζ folding control element is not formed in absence of Mss116p 
would suggest a focus on possible interactions of Mss116p with this region of the 
intron. Since Mss116p has different activities, namely unwinding, ATPase and RNA 
binding, it would also be interesting what importance those activities have considering 
the structure of ai5γ. 
As ATPase activity is essential for splicing of ai5γ in vivo DMS modification of a strain 
carrying the K158R mutation that was shown to reduce ATPase activity tremendously 
(Solem et al. 2006) would be a logical next step. If the proposed mechanism of 
Mss116p were correct the resulting DMS pattern would resemble the one obtained with 
a wild type strain. Differences that relate to undocked domains and an immature active 
site centre would strengthen our theory. An occurring footprint would be consistent with 
our suggestion that the ATPase activity is needed for cofactor release. Structural 
probing of strains with differently truncated C-terminal domains might shed more light 
onto the function of this distinct and highly positively charged domain. Furthermore 
DMS modification of a strain with the SAT -> AAA mutation that uncouples ATPase 
and unwinding activity would elucidate the role of unwinding activity in native 
structure formation of ai5γ. Finally a strain with a disrupted κ−ζ folding control element 
would help to confirm the importance of this region for the tertiary collapse of ai5γ. 
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Anhang 
 
 
Zusammenfassung der vorliegenden Arbeit 
 
Das Gruppe II Intron Ai5γ, welches im mitochondriellen Genom von Hefe zu finden ist, 
besitzt die Fähigkeit sich selbst aus dem Transkript herauszuschneiden. Um dies 
bewerkstelligen zu können muss dieses sehr große RNA Molekül eine komplizierte 
Struktur einnehmen. Die Faltung ist dabei in vitro von einer hohen Konzentration an 
mono- und divalenten Ionen abhängig. Im zellulären Kontext, wo diese hohen 
Konzentrationen nicht verfügbar sind, unterstützen Proteine bei dieser Aufgabe. Im 
Falle von Ai5γ wurde das DEAD-box Protein Mss116p als notwendiger Kofaktor bei 
der Faltung von Ai5γ identifiziert. 
In der vorliegenden Diplomarbeit wurde das Gruppe II Intron Ai5γ in Bezug auf seine 
Struktur in vivo untersucht. Dabei war ich insbesondere an strukturellen Unterschieden 
von Ai5γ zwischen einem Hefestamm, dessen genetischer Hintergrund dem Wildtyp 
entspricht, und einer Variante, in welcher Mss116p durch eine Resistenzkassette 
ausgetauscht wurde, interessiert. Dadurch sollte die Funktion von Mss116p im 
Zusammenhang mit RNA Faltung beleuchtet werden. 
Um strukturelle Information über Ai5γ im zellulären Kontext zu erhalten, benutzte ich 
Dimethylsulfat (DMS). DMS penetriert die Hefezelle und ihre Kompartimente rasch 
und methyliert N1 von Adenosin und N3 von Cytosin, wenn diese nicht durch 
Wasserstoffbrücken oder gebundenen Kofaktoren geschützt werden. Diese 
Informationen geben Aufschluss sowohl über Interaktionen auf der Ebene der 
Sekundär- als auch der Tertiärstruktur. 
Nach der Optimierung der Methode habe ich zuerst die Struktur von Ai5γ in vivo 
untersucht. Dabei stellte sich heraus, dass, bis auf eine Ausnahme in Domäne 2, alle 
Sekundarstrukturelemente, wie zuvor postuliert, ausgebildet sind. Außerdem sind alle 
Tertiärinteraktionen bis auf eine Ausnahme vorhanden, was darauf schließen lässt, dass 
auch das aktive Zentrum des Ribozyms in vivo ausgebildet ist. Modifikationen der 
betreffenden Bereiche zeigten, dass der größte Teil der Ai5γ Moleküle nicht mehr an ihr 
Substrat gebunden sind. Konsistent damit fanden wir in einem “in vivo splicing assay” 
heraus, dass der Großteil der Population im geschnittenen Zustand vorliegt. Daraus lässt 
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sich schließen, dass das Gruppe II intron Ai5γ nach ihrem Herausschneiden ihre 
Struktur inklusive aktivem Zentrum erhält und für den Vorgang der Reinsertion keine 
bedeutenden Änderungen der Struktur nötig sind. 
In einem Hefestamm, bei dem Mss116p entfernt wurde, zeigte sich, dass die Struktur 
von Ai5g stark gestört vorliegt, was sich auch im Fehlen von geschnittener mRNA 
zeigt. Die Sekundärstruktur bildet sich hier nicht aus und bleibt sogar unter dem Level 
von ungefaltetem Ai5γ in vitro. Sämtliche Tertiärinteraktionen fehlen ebenso. 
Außerdem wurden keine Anzeichen gefunden, dass sich Ai5γ in vivo ohne Mss116p 
falsch faltet und in einer sogenannten kinetischen Falle verharrt. Ebenso wurde kein 
Fußabdruck von Mss116p identifiziert, was darauf hinweist, dass Mss116p nicht mehr 
am nativ gefalteten Gruppe II Intron gebunden ist. 
Meines Erachtens deuten die Ergebnisse dieser Diplomarbeit darauf hin, dass Mss116p 
in einem frühen Stadium der Faltung von Ai5γ aktiv ist, da bereits die Sekundärstruktur 
stark betroffen ist. Da bekannt ist, dass mehrere transiente Zwischenprodukte in der 
Faltung von Ai5γ entstehen, scheint Mss116p eines dieser Intermediate zu stabilisieren. 
Um die Faltung in den nativen Zustand zu ermöglichen muss zuerst Mss116p das 
Gruppe II intron freigeben. 
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